From: Subject: =?Windows-1252?Q?eLymphNotes:_^^Florida_Protocol^^_Medicare_and_Lymphedem?= =?Windows-1252?Q?a=97How_it_Came_to_Be?= Date: Thu, 24 Jul 2008 19:31:49 -0400 MIME-Version: 1.0 Content-Type: multipart/related; type="text/html"; boundary="----=_NextPart_000_0000_01C8EDC3.EAE486B0" X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3198 This is a multi-part message in MIME format. ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable Content-Location: http://209.85.215.104/search?q=cache:oMX91M_M6yQJ:www.elymphnotes.org/detail.asp%3Fci%3D23%26it%3DIPI+Florida+Protocol+lymphedema&hl=en&ct=clnk&cd=1&gl=ca eLymphNotes: ^^Florida Protocol^^ Medicare and = Lymphedema=97How it Came to Be This=20 is Google's cache of http:= //www.elymphnotes.org/detail.asp?ci=3D23&it=3DIPI.=20 It is a snapshot of the page as it appeared on 5 May 2008 11:59:59 GMT. = The curre= nt page=20 could have changed in the meantime. Lea= rn more=20 =BB

These search terms are highlighted: florida protocol lymphedema  
3D"eLymphNotes
3D""=20
3D""=20 3DUltimateHealth=20 3D""=20 3D""=20
3D""=203DHome=203DForums=20
3D""=20
3D""=20 3D""=20
3D"Subscribe
3D""=20
3D"Make
3D""=20

3D""=20 Link to=20 Us
3D""=20
= Log=20 In
3D""=20
Subscribe

Contributors
=
Advertising=20 Info
3D""=20
Product=20 Showcase
3D""=20
Classifieds

Press=20 Room
3D""=20
Ed= itor's=20 Desk
3D""=20
Fea= tures

On = Bandages
3D""=20
On = Marketing
3D""=20
Pat= ient=20 Corner
3D""=20
The= rapist=20 Corner
3D""=20

What=20 is Lymphedema?
an abnormal swelling
of the = body...Read On

See=20 All Core Content

3D""=20
3D""=20
3D"" Home  >&nb= sp; Past=20 Issues  >  ''Florida Protocol'' = Medicare=20 and Lymphedema=97How=20 it Came to Be

''Florida Protocol''=20 Medicare and Lymphedema=97How=20 it Came to Be
by John M. = Macdonald


In 1971, I had completed my training in = Vascular and=20 Thoracic surgery at the University of Pittsburgh and St.=20 Bartholomew's Hospital, London, England. As I began my = career as a=20 surgeon in Ft. Lauderdale, Florida, I never=20 imagined the twists and turns that would lead to my present=20 involvement in wound healing and Lymphedema. The=20 specialty of cardiovascular surgery is rich in mental and = physical=20 demands and for more than 27 years I was involved as an = active=20 surgeon in private practice and as an active member of local = and=20 national medical organizations. Two experiences during these = years=20 redirected the focus of my career. The forces of change = began when,=20 in 1987, I traveled to the nation of Haiti. At that time,=20 Jean-Claude Duvalier, ( Baby Doc), had been removed from = power and=20 the government appointed General Henri Namphy to be the head = of=20 state. A number of years prior to that time, good friends of = the=20 general had come to the United States for elective surgery = under my=20 care. As my friendship with the Haitian community evolved, = my wife=20 and I were asked to visit this fascinating country one and = one-half=20 hours flight time from Miami. Shortly after our second = visit,=20 General Namphy was exiled to the Dominican Republic. By this = time my=20 fascination with Haiti and my contacts within the Haitian = community=20 had grown considerably. This allowed us to return to Haiti = many=20 times over the next 13 years with opportunities to visit = medical=20 clinics, interview physicians and nurses while enjoying the=20 friendship of Haitian and American governmental personnel. = Haiti was=20 unlike any nation in the Western Hemisphere. In 1997, there = were 7.2=20 million people in Haiti with fewer than 400 hospital beds in = the=20 entire country.

One evening at a cocktail party in=20 Port-au-Prince, William Swing, the American Ambassador to = Haiti at=20 the time, said to me, "John, what is it that you are doing = with this=20 new clinic you are developing in Florida"? I=20 began to explain my interest in wound healing and the = relationship=20 to Lymphedema=20 when He asked, "What is Lymphedema?"=20 This was followed by, "Is that the same thing as = elephantiasis?"=20 And, "Did you know that there is an elephantiasis colony in = the town=20 of Leogane?" "In fact, the Center for Disease Control has = been=20 working there for a year." The town of Leogane is a once = prosperous=20 town 30 km. south of Port-au-Prince. The area is very = tropical with=20 abundant moisture, greenery and verdant pastures, very = different=20 than the deforested majority of the country. The blessing of = the=20 fertile soil is balanced, Haitian style, by the abundance of = mosquitoes. In a population of 120,000, 5% of the people are = afflicted with filiariasis---leg Lymphedema being=20 the most common limb involvement. 30% of the male population = is=20 afflicted with genital filiariasis. It was evident to me = that I had=20 to visit Leogane and see what kind of pneumatic pumps the = CDC was=20 using to treat filiariasis.

The second event = redirecting my=20 medical career was a phone call made to Marshall Webster, = M.D. in=20 1992. Dr. Webster is Professor of Vascular Surgery and a = former=20 fellow resident in thoracic surgery at the University of = Pittsburgh.=20 Dr. Webster had published an article on wound healing and I = noted=20 that The University of Pittsburgh had a clinic, founded in = 1988,=20 called "The Wound Healing and Limb Preservation Clinic." My = interest=20 in this field was further stimulated and eventually, in = 1993, I=20 founded the North Ridge Hospital Wound and Limb Preservation = Center=20 in Ft. Lauderdale, Florida. I began=20 to learn more about wound healing but also, and probably = more=20 important at the time, wanted to increase my vascular = surgical=20 caseload. Not knowing the difference between algeron and = alginate,=20 alginate being an everyday wound care dressing, I began to = attend as=20 many wound care conferences as possible and slowly developed = knowledge and an appreciation for the fascinating specialty = of wound=20 care. Also, I had become aware that the majority of the = physicians=20 in the United States had little appreciation for the value = of this=20 new/old discipline. There was an obvious need for physicians = to=20 become involved. Knowledgeable nurses were frustrated with = the=20 inability to gain acceptance for this new discipline. Sadly, = this=20 scenario continues in our hospitals as this article is being = written.

In January of 1997, we returned from our = second=20 Leogane visit. Daily, we were impressed by the clinical = improvement=20 achieved in a primitive setting. One physical therapist with = only=20 basic Vodder training supervised the program. The results = were=20 impressive. The staff of seven to ten dedicated trainees = tended to=20 hundreds of Lymphedema=20 patients. Outcomes were recorded and evaluated by the CDC = under the=20 direction of David Addis, M.D., a physician in the Public = Health=20 Dept., Atlanta, Georgia. Returning from Haiti, I was = convinced that=20 Comprehensive Decongestive Physiotherapy was the standard of = care=20 for Lymphedema.

That=20 month, Holy Cross Hospital encouraged me to give a = presentation at=20 their weekly public forum called "Dinner with the Doctor". A = newspaper advertisement appeared in the Sunday edition of = the local=20 newspaper - "Lymphedema,=20 Diagnoses and Treatment ." The following Wednesday, I was = startled=20 to discover an audience of 350 awaiting my lecture. I asked, = "How=20 many of you are here for the Sweet and Low and how many of = you are=20 here because of Lymphedema?" The=20 majority raised their hands for the latter. During my = presentation I=20 apologized because I realized that main stream American = medicine had=20 ignored their plight. At that time, there was one clinic in = Ft.=20 Lauderdale offering CDP. However, to my recollection, this = was the=20 only clinic with a physician director in the state of Florida.=20 Programs offered consisted of the European standard of two = sessions=20 a day for four weeks. Very few insurance companies would = reimburse=20 for this protocol. The=20 average cost of $10,000-$15,000 was prohibitive for the = majority.=20 Clearly, the suffering Lymphedema=20 population of Florida deserved=20 better.

For a number of years prior to these events, = Medicare=20 Florida had=20 been repeatedly petitioned for acceptance and reimbursement = for CDP=20 as the the standard of care for Lymphedema. Dr.=20 Robert Lerner, a pioneer in the introduction of CDP in the = United=20 States, led the drive for medicare reimbursement in Florida. He was=20 assisted by numerous in state and out of state Lymphedema=20 activists and lobbying groups. The core of their petition = requested=20 the standard program of four weeks of therapy with = twice-daily=20 therapy sessions. In keeping with the European system, = patient=20 education and outcome documentation was not stressed. = Medicare's=20 response to this drawn out, intense lobbying effort was = detailed in=20 an advisory dated October 20, 1996, written by Sidney = Sewell, M.D.=20 Dr. Sewell was, and remains, the Medical Director of = Medicare Florida. Dr.=20 Sewell stated then that Comprehensive Decongestive = Physiotherapy was=20 considered "experimental." As far as Florida Medicare=20 was concerned, the case was closed.

Because of the = Haitian=20 experience, I was convinced that professionally presented = medical=20 logic could be used to reverse this decision. It was very = apparent=20 that unless we could obtain some form of third party = reimbursement,=20 we were never going to be able to support my vision of an = integrated=20 wound care-Lymphedema=20 center. Nancy Sims, a registered nurse, certified as a Lymphedema=20 therapist, had been working as a freelance caregiver in Lymphedema in Florida since=20 the late 1980`s. We met at an NLN conference in San = Francisco in=20 September 1996. She shared her extensive Lymphedema=20 experience with me and it was obvious that her dedication = and=20 professionalism were exactly what was needed to conduct a = new Lymphedema=20 assault on Medicare Florida.=20 Attempting to gather documenting medical data, we contacted = the=20 original medicare petitioners. To our dismay, we were = totally=20 rebuffed. Sadly, even requests for reference articles were = refused.=20 I was told personally by an out of state lobbyist that "This = was a=20 business matter and that she had not received permission to = assist=20 our efforts." We discovered that there were a number of main = stream=20 Lymphedema=20 leaders in the United States with little sense of = professional=20 collegiality and, in fact, appeared to be severely = compromised by=20 economic and territorial concern.

In retrospect, this = experience strengthened our resolve. Nancy and I, together = with a=20 local chiropractor gathered volumes of current world = literature. We=20 were extremely fortunate to receive advice from Judith = Purtell, an=20 occupational therapist practicing in Milwaukee, Wisconsin. = Her=20 insight into the practical aspects of therapy proved = invaluable.=20 While the input from each of these sources was important, = the=20 Haitian experience ultimately provided the catalyst that = captured=20 the imagination of the authorities. If we could achieve = these=20 results in Haiti, under primitive conditions, why not Florida?

Once=20 our review of the literature was completed, packets of = information=20 were sent to five highly regarded physicians, practicing in = Florida. This=20 group included the specialties of Oncology, Physical = Medicine,=20 Cardiovascular Surgery and Vascular Surgery. I spoke at = length with=20 each of these physicians. We reviewed the statistics from = Leogane,=20 Haiti as detailed by Dr. Addis and the Center for Disease = Control.=20 We abstracted what was available in the English language = medical=20 literature. When each of these physicians was convinced that = CDP=20 offered a viable medical option, they agreed to write a = supportive=20 letter to Dr. Sewell. In response to this independent = physician=20 input, Dr. Sewell agreed to review his previous decision. = Our clinic=20 then wrote a new proposal that would allow the essential = aspects of=20 the European system to be defined using established CPT = codes. We=20 felt it very important that physical therapy time limits or = monetary=20 caps not define the program. It was essential that the new = protocol be=20 medically correct, attentive to American socioeconomic = realities,=20 easily documentable and fraud proof. It is important to note = that=20 documentation of functional physical and occupational = outcomes were=20 stressed by the Medicare evaluation office. Medicare then = evaluated=20 our recommendations and those of other interested parties. = To the=20 enormous credit of Dr. Sewell and his staff, the "Florida Lymphedema Protocol" became=20 law one year to the day after the original denial. October = 20, 1997,=20 was a day for celebration.

In essence, the "Florida Protocol" has=20 five basic directives. #1 Diagnoses of Lymphedema must=20 be made by a physician. #2 The physician must write an order = for=20 CDP. #3 The patient is evaluated by a physical therapist = prior to=20 therapy, at midpoint and at the conclusion of therapy for = functional=20 impairment. #4 Patient self-education is stressed and, in = fact, if a=20 patient is unable to continue self-therapy either by = themselves or=20 with the cooperation of a caregiver, the patient is = ineligible for=20 the program. #5 The therapy is limited to ten MLD sessions. = The=20 determination to limit the basic protocol to ten=20 MLD encounters was made by the medicare office. With = emphasis on=20 patient education and functional outcomes, we believed that = these=20 conditions were realistic. In response to medicare approval = we also=20 felt an obligation to document the results of this new protocol. It is=20 emphasized that the standard European protocol=20 consists of four weeks duration with twice a day MLD = encounters.=20 Patient self-care education is not stressed in the European=20 system.

We knew immediately that this ruling would = open Lymphedema=20 therapy, at a reasonable cost, to thousands of patients in = our=20 state. We also recognized that while the four-week European = program=20 is the gold standard, a significant number of patients would = benefit=20 from the ten-treatment program. The original directive = stated that=20 it was understood that some patients would require extended=20 treatment sessions and that these patients could be reviewed = for=20 approval on an individual case by case request. Numerous = articles=20 concerning the Medicare turn around were written in the = ensuing=20 months. One article in the Miami Herald quoted a prominent = national=20 Lymphedema=20 authority who said, "Were this ten session program accepted=20 nationwide, it would be tragedy for the Lymphedema=20 patients." It was implied that we had distorted accepted = therapy. We=20 countered that a half glass was better than an empty glass = and began=20 treating patients.

In June of 2000, at the Symposium = for=20 Advanced Wound Care in Dallas, Texas, we presented the = statistical=20 results on 232 patients treated since opening in 1997. From = this=20 group we recorded the volume reduction and percentage edema=20 reduction inpatients receiving exactly ten treatments. We = compared=20 these results with previously published German, Australian = and=20 American reports using the four week program. Our results = were=20 essentially the same as the Australian reports and = comparable to the=20 German and American four week findings. We concluded that = the "Florida Protocol"=20 compared favorably to the traditional methods of therapy in = stage I=20 and II types of Lymphedema.

The=20 journey to arrive at our present level of care for Lymphedema=20 patients in Florida has been=20 both frustrating and exhilarating. Obviously, we are just = beginning=20 to fulfill our obligations to Lymphedema=20 patients here and throughout the world. We are adjusting and = refining our approach to the Lymphedema=20 patient and to the relationship of wound healing to the = variables of=20 Lymphedema. I=20 am excited that with each visit to various cities, hospitals = and=20 clinics, I can see a growth of awareness. The dedicated = efforts of=20 the original visionaries both professional and lay public = are=20 beginning to take seed. The accomplishments and growth of = the NLN=20 have been and continue to make significant contributions. = Patients=20 previously ignored are receiving proper attention. There is = strong=20 evidence that the main stream American medical community is = becoming=20 involved and that in the near future it will be the = exception rather=20 than the rule to have large areas of North America without = accepted=20 Lymphedema=20 support. I speak for each member of our center and for the = many=20 dedicated friends who have assisted and continue to assist = in this=20 effort. "We are proud to have made a difference."

Florida medicare=20 mandates the use of specific CPT and ICD-9 codes, and = requires that=20 certain conditions have been = met:

Conditions:
1.=20 There is a physician documented diagnosis of lymphedema: and=20 the physician specifically orders CDP 2. The patient is = symptomatic=20 for lymphedema, with=20 limitation of function related to self care, mobility and/or = safety.=20 3. The patient or patient caregiver has the ability to = understand=20 and comply with home care continuation of treatment regimen. = 4. The=20 services are being performed by a health care professional = who has=20 received specialized training in this form of=20 treatment.

ICD-9 diagnosis codes: 457.0 - = Post-mastectomy Lymphedema=20 Syndrome 457.1 - Other lymphedema 757.0=20 - Hereditary edema of the legs (congenital lymphedema)

CPT=20 Codes:

97001 - Physical therapy = evaluation

97002 -=20 Physical therapy re-evaluation

97003 - Occupational = therapy=20 evaluation

97004 - Occupational therapy=20 re-evaluation

97110 - Therapeutic procedure, one or = more=20 areas, each 15 minutes: therapeutic exercises to develop = strength=20 and endurance, range of motion and flexibility

97140 = - Manual=20 therapy techniques (e.g. mobilization/manipulation, manual = lymphatic=20 drainage, manual traction), one or more regions, each 15=20 minutes

97535 - Self-care/home management training = (e.g.,=20 activities of daily living (ADL) and compensatory training, = meal=20 preparation, safety procedures, and instructions in use of = adaptive=20 equipment) direct one on one contact by provider, each 15=20 minutes.
3D""=20

3D""
About the Author:
John M.=20 Macdonald
John M. Macdonald, M.D., F.A.C.S.M
B.S., = University of Notre Dame
M.D., University of Pennsylvania = School=20 of Medicine
Internship--Jackson Memorial Hospital--Univ. = of=20 Miami
Residency General and Thoracic Surgery--University = of=20 Pittsburgh
Fellowship, Thoracic Surgery--St. Bartholomew=20 Hospital, London England
Board Certified--General=20 Surgery
Board Certified--Thoracic Surgery
Private=20 Practice--Thoracic/Vascular Surgery --Ft Lauderdale, Fla.=20 1971-1998
Medical Director, North Broward Hospital = District,=20 Wound Healing & Lymphedema=20 Center.
3D"" 3D""=20
3D"" 3D""=20
3DSponsors
3D""=20
3D""=20
3D""=20
3D"The
3D""=20

3D""=20


Advertising=20 Opportunities

3D""=20
    Links to external websites were active at = the time=20 of posting.

3D""
Home  |  Current = Issue  |  Events  |  Terms &=20 Conditions  |  Privacy=20 Policies  |  Donate  |  Link to=20 Us

=A9 2008 eLymphNotes, The First = Online=20 Magazine on Lymphedema
Published=20 by The Lymphedema=20 Awareness Foundation (LAF), The Community Network
172 = Lakeside=20 Circle, Sanford, FL 32773
laf@elymphnotes.org


3D"Designed,
   
------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/lg_elymphnotes.gif R0lGODlhkQBJANUAAOrGu8/l7CiPrvXi25ylo5DG1uK1p221yfjq5KLM2BCGqMHKyQF7oE6lUq7V 4delmPz9/AB0m/vw7J26wfLZ0eeol/rVyUSVr06jvObz9u3Uy3mptlyrwsO2s+rNxP328/b6/Nmc jv359rrInd/Z1eW9sMnZ2lx6nDZtiuHo4ODit2ifrorEc3aPme61pDFUkfDx8PLPxe73+ezv1dvt 8mesbkSIeH++0Dubt+Gikvb39B15quCuoL/e6AFnpv///yH5BAAAAAAALAAAAACRAEkAAAb/wJ9w SCwaj8ikcslsOp/QqHRKrVqv2Kx2y62yWN2weEydNRpgsnp9hZiatXNjRgbRAngaiM1ngnwFSwty LHRcGQ4HGAIKjY0CGAcOGX2VRRc7ShlyDSMiWjQ3ODgcNwkOPQGpPQ4FigKkPVYZqXuWTDc+G0Mg DkQ1NmcjKp9XIAUKAjeUTKECDBgBUj0cCgwMAtK3SjA+PjA/EDu6Qgs25yzEWAmQPTJRED0HCji+ TQ7POAUOCRgMCduUCPBx4UcAbwIgwDhno8aIGRCsQJhXIGKVABgUHGCGJACHCPWIgIAVMMkGbxNI DNygogWKcw8tUpGBQwANUIxuHinAIMKB/yM3BNgqWeQgQRMLJozY8BIFARVDqWTUhgRChgxRldDI CJCIjAMRFHQ1UkAo0SPjfKRUsQCF2xYqZFK5oUDnEQgJcDQK6eQGg0BCaEbYQdUIBxxnj6xAqCLF iRcoToxIcaXHvyTHBBzokVeBA7lKeAbqgSNCNswaExsxqnbCC8jD3lmpmZUXO8AG6clygqxa2MJG LANX/SPtiscvCMzQcSUAA3tHAoy6iaiaghu1k4ANuxsJCBw3iBtZ7KPF6xYzilmpll0IPhyvIBXo wZGJA2sRwiuhC1q8jBUrjNACXB9gIUNqSSCDQwI96DGNAhEwkEx9RfTgmXhGTHBCCxPscP8BRFjQ EAFuQCmAAYVP0CBABGE5wIB+qyGI4RCuvXACeQtkEcCIodEzXBMqRvjcDxZ2N0QAJraXGAwonHeB Nxv0Nw2PSeBz3V1SBvZRTxwMgQEGciWgAAdZqobcCx0Q4M0O4FSWnxLSMYCDXeG0guIQYPWkAEcZ YDfEDRF0OSMRK7j1AlwqDKRWmU70AFKZMiDDAAfaHLNgexYKCV0RNIAF46A/tOWWZCOYcJIPK7RZ BQ09GWlEBv6EhQEHjBzQHpIRgoTEfRFs2kYXNJzjlnIiiPDBQDu8YcWBIClpkG8sClCAbEdgIOSQ nB6Aja9UgBDADWRuAYGwToEohAkoMdr/xHYFiCDBu/DC+4EEASRwCgzzxitvAtf0dEC+EnzwAV2B 4qvvwQgf/AEypukg8MMfFCtxsRBUvAQwNqBAYBEDFXQFDRBeNwAFJJdsMgUDDGDBySeLKaQAJJRM wgErXrAAyzjnnPMC2KTsMwJAA62vwGUOwtAIEqgnRAo+7MCcFRJYy+IEFFigwdVYYx1D1lxfTcEF QgZqwcrssMgBCVZ3rfbaWZc8gAAC+Cx30ELLm2UKZ5xDQNJHPDkWFQN0sOI1GCwAQAmIJ6744ooD MEG/2CzQAa0srtDB4YxnrvniAHQOgAdwe7C1BibPXbfSQ+iQd0MqFHhENxekcKcTGrjQ/wGEem5g AA8u8OD778AHz4MB1lwDUqxhTVDC77sL7/zzvu9uQOJwe+6BB1i7nXLQrhfBghw2xJTEBBM8TYUG IeRAwODXCHDBBh3wUEEFOdRvv/3zu7AC5MYzcAEBD8hBCAYowPQJ0H4DJGD9EhiCBzyAgOl7APPg 1rjOiY50JPsZ6oSggzjYIB3qslgV0BeCCnTgAj3pnwIusAICuPCFMNzAClAIubBcYAIuoF/65leB 9LkwBw8AYACBGMQADrACGyBADirgQPpJcHgULIEFr4c9r6FsAEDrXhE6WIPWsWEAUpRiDCYAoWtd q1/FMx6L+Fe4DcgQAxsAwAYwACAPLP9AARuIAQ0x8Dkc9EQAhvPABhgwgRhs4AI31IAHPqcBuFFg ARegBwnkhsWgwYtiRphB69SVhQF4rnMxWMAKnrFG/qVQjfwTWwy0BY0JeGACjNjAAqz1ikhGYAIH wMEMI3ABO1rjFWXkgAZisDW4mWAUEOIAAkyHAHlFTEoiXAMCqEhFYmpgAblMoyn3ok0GLCAGALAA BxhAAnBaIAFUI2PyqjaBCHFgbF+LwDcBpYAJXO1xt6QA6eAGyJRZKwF0q1vAIrZBIViFWmSYJjWr OTZFLiAp5JvAQx+qgcf1KwIYGKYHLMCzG1iAmDeYwNjauYGPFhNmxLTABm7JUUJaQHT/FgAUzEj2 jAT4zAT56QfdnCmC/mQgm2NCaBgUGgPRGbWaw4zB2MZGTKVagIbXUMACXnpBelAgBhQonFIfdwCq ZlUAitzo40TKswRQtZjypGncfEYCE0FDAgIdaE8rRMqe9EoNEqCkXvc6Nxdd9AbL/Jm2SIAAE2Bg ewnIT2ARsIjFJjYBEihrYLHoKbjCDa7NhEHxHDAviEkMNOCiD6BapYYPBPS0qN1paSCXAswK7bEL +1czHeATzH5gEZiVwGMlYILnuFa3tYXBZeGlgxUJAF8Po1jF5HIDDNgCZBgVahfclbDqyqsAZiwA wN71AZweQASb6Sxtb5Cv2+KgvI8V/4FlEgCwD9C2XcIVgMMiptlAQeCzyw0HEW6wESJkIACcbAPE BkzgAYuguGHDwXw9q1kFF2C+IhgvBIiGAQUT7bFu+MeEicaTHkCguAlZrl94FE2gYEC6fDBtalec RexeFLKolUA1AuCA3Cb2ALnF7WsjwN7ewjiLuJVAfLlbFmt8xrPKFUICOOAsvPL1ydszwTP6dYDJ UhIBLpLEYheg2JRFDQd5xeJjCxuoMBf2L0Ebrowl1YPyJrdYP6ABDn7UhzBDea+MDZsArKxXBDxj ktsDFA5SkDITNMIE2wNLlXv7D6AhCQfbQ0Aj2lyASv9GYQITAQgw4KpbIIBtbKNAW/8hRzVQD4BW +rxaLhGJARLkBW4LokBQ4HaDO+IgEhsgRcwGgE1+5hIjv7GkM3XAAUERRaELTfZCY2At43VV2dQc o0cXejVqUxEA1bYjA7r60I2OjgQxQ5k+UhAyE+wUXngBU4DJQIHhGeDd8I63vF1g0Z7gwAAukLe+ 6d0Bffv737bDowvyDe/GhbKr9TbBFSPN2znNlSgUcCDwnvg7ivOu2aaJH/R+5wL4VSB4H69ADkU+ P+fdbgO9s/i7EQeAG6o0QlK12sIRIFztfmDdYxjA9DbHuUH263I8T1wHNsC4zg1dhkjvwCIXx7M4 cs5zY8TA2LbEAETPTQL8fRhoQND/Xz60e+PAMyHkUA523nV8Bb3jnQEmsAL8sKiUAiB62gNO9uit nOUcMFwMViCkm838mDAYKGhARic1UODjZedBCaBKgLSDfQUbEED8RB55u0pIlwCKpJ4aL7/boT14 d18BBsDpAbBdQ+EZxCIGbB4xI/ALRfEIQFbkIQkUv0oVDnDABIRoRAYy8AH7u8YGCuj74hOARcMP QQf2FyEW8r5+DiRA2xmwAR/K6YEJJKIJJZ/vxfd9dBoYQAJw7AD+3qAAOunFMwqQgPkIoQcVHgVV ypLLQC1hK2V8e78E0MLJzy+AHWdXG+BERBRABghE0KdLnVdGOBA/SzREDlQ/8yM4/xEwdGk0gBLn OyWAATjEcqsVc6QzAIaWAtpSACnQKRdyH1EFN6PxFz8AAnQhDaxiDzSjJC5DD18yCoygfyayAROg dBagTi71SURYhNgDTgCwWhugAUXYhKE0JnY0UQuwSJ8jVhigTyVTGmFhbpVUCvySAPcVEX4UADIA K3UBAhGRAZpBBCbyA/yiEzLAAbZnGTyGhkOQV64GLUJCD+NkGg7AZ3cmWBECUIH4M3dEaHxVWApg bnTzgQHAXdSgA/TwAz0VEY4iKBlBLYCSAHfAGdeQAdiFGzKQJdZCIgb1THFWAIuQQqXEAT2QAj01 MZ5FYMWCKxVRYLgYMTKQDcZSYP8iwAG3KDGbBnM0UDE0wQo+UQQHwgDSkBEc4Q+z8iVfIoc7Ihaz Y1CMsG4gAH+Wh0au2GREEAArYmxQAAE40Gl4ggFHsCUKIBuK8AMf8SlCEI8/4A/MAAGMgBV2SAQf 0SJJAAEfgY53URYY1Ye5EiGwcAAFQIZHQAMF4EemcY1K8B2zQxqFN4/RsgdbkQHmeFdFACg/4YxC MBIMMDsyUDbblgTOIQASGQ6kERYVQSR6aFdrBAsccAA4eRhlBI1U4BFIADLcIgSAYhoRwQEA0ZHc ApL1uCcj+QwX6RVg0Y5V0ggHAGDKKA/PgAGcyCk9IAr6p0Zr9HaBogpvIgWbFpT/3yGPRJBYuiId svERpgiPPhAeeiEb+OiRFWIXm6gJ44QNN3kAHLCKY0JnvOAAtEKTYhkW5+gePDYFQZEdN6kELoJR P3AD0HFjRXCXslCXXpKMIgGDYwECChCXr8IZN3CaleYADPkEMkBjBQAuN8l+dGIZQTmROIligOks zpEfDgAmvDCJREBbmFiSBpVYLzIEFmmYRIABtXkWrBKX7ZEBSyaHRhCHvqkJEJJLvsIT0PEddSEE ntKVYLgdGMBfykAkI4KGD4lzlYCP5Aie5ZkKqqCKAuCKR5AB4NEEB6IRaumGk8IKsGAXQbJtzDBi pqENMuAPNvmUxMEOWdEngSmNjJEgkKTxE/rZCBzAoNRQbDcgVIgAHPXiAFlRLwKJIYD5j00WFIRp BNBloaASECpSAOAYHIqwosGBDQz6onxAE3PiBBDgEXwBBdj1Nzq6DSf5JVt5BDIgD+UpolOwCLZX pJUAAuwACQdwCvwALjVRlVXwHSUqpZYAATTAGe1nL6cge8Zgo2C6pmxKBEEAADs= ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/c.gif R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/image_uploads/homepagead1.gif R0lGODlh1AE8ANU/AAByZgAGBwCplQCEdQAVGwAaKgCYhwBxvABLQgA1WABmpwBHcwB0wgCxnAAh NwApQxIVFgBZkwCumQBEPAA7NQBnXABrsgAxKwB6ywBViQC4ogBRRwAuKQCkkAApJgELDwAlIQFc UwAxUACfjBCunABfniUlJQAeGwA8YhB7wgCslwB8zxAiJwCOfgBNfgAQEQCbkABPVgAfLgCA1QB3 xhA/XRAuKhEoNBCzoACnmgAuTACnkxAQEBcXFwAAAP///yH/C05FVFNDQVBFMi4wAwEEAAAh+QQF yAA/ACwAAAAA1AE8AAAG/8CecEgsGo/IpHK55Dmf0Kh0Sq1ar9gnhGdr2bLgsHhMLpvP6LQaCjG5 3yamfE6v2+/4/JDn6/v/gIGCg4SFhoeAFRoAH4iOj5CRkpOUlZaXmH4BEHqdnp+goUyNmaWmfhQd Kg0Vp66vsLGys4Obore4ubpIpLS+gy8DDQIqKgi/yMnKy662u8/Q0XcBzMkhwwICEiMe1d7f4N/O 0uTl5j3U4bEeIyrZ2Q0DL+r09faY4+f6+6Lp95kBhL171wCAv38IEyrMx6+hQzsHFU7aIMHdQGIq YkjcyDEcw4cgQx6J2BHRCQMSLr5TkYNCSWAFeoF7QfPEiXkvX30UyTMkyf+ctQBgUwnPAAigfwo4 wAkugAcOHC5cOIrU1M6eWPn9rPpnwlCi8ORxVcpUXNQLUalyxccpq1uHW9eeaJES7EBWY5eqc4o2 7VqAbd8KPhc30AcCiAkUKFwtAIC6dlcKQMC4T4B0ES//1Lw5EOdCZDVpRnT5A80XHy4bCvDBNOrU fKFOFcT6NGqSpVs3qn1bk+vetHnTbF150tXByHMV76PDgnMFDFD8o6ACcmR4I2QcClBgMXcCPgIo liGjAGJqAV6ML1+g7AfzfUx3J9+dQOpAZNPP725e5p8PJ4BwllRoeXCTIC+c4AGBUnEAwglRyaZW HwkuyOAFBhLgD4QEgvD/goVSGageiA16CMiHAxLooIbNBJbci7os5wMBJdDAwI0WFGDPC3RdN5AK O4TgAHiEcDekDx84IINi5tFEgAMOtFdAeQQ4CWVMFEZ5mAxRmoeYUkoS6YdS3UVpG5hiWsbhhRc6 6A+AKqbYIFR+UQgCmw0S6AGRJ/RFZ5x5MigbWmX1yeagIMhImoswNhqKogvQcMCkNCxgzzU+3lWB kWkC8qSOSHIpQ1nhgYnlH0aC+oKSXNrn2QtkJnUlSR9w2UsAd/aFFgi8PjUoB/O8cNavHlhIp4QU GlsgrwL+ecEJAfR5bIERyhbhU37OZtlTzPJabZ2lHOfouBBB4sCkkzKQ/yM9HKiSaVjz1HpkIKvK QIq8pGbpgH/xKamvvYWkmg6ZW60Kqg/SnnUCKS/cOSAHGn47lX215frnUR/q6sEL6HE4LAhwXsyx sH5ysHF6vkZISnro+fHBgtaeIi65NDOh6AvQoUtDBorC8oFA70pgQDfxcUlqknoVLcNPSS5Nm78+ rJp0wEoRGRowUVI45wXgiYdtiRwjnC20gSTsl8NRedAIgIOitTA1CUvFlNlc+xE3sH4k2O0JBNwt M6M1By5HzyhImi4DD4RzjUU+FjPBiUreWvV/5DEduSBNZ+n0IZ/2cTWCWYttbYIpGigT2hhuBrNf qz/bcIogsGi3rnj3Qf83UwTQHqyAeE7Lwd+CBz9Hzw8wgO4BNETQ8ynsWBdZdZsG8uTmnx5U6+aA NM0vklAb7Ij3PnxOb+hmy+lhZqhzsH1sabEvJwcHlq377H/irnsAw7qN2OoRAi/8/0noGQFyhi4G 6MAbHxDKuwQQj3x5LkrpUVJErmc5gBmme1AqzuTCN7XxqWpOstlTWVRju7GRhG5HQduxYme9P9xt btmyn7VMozGmRIt2/gOgDonQswBkwHgFjMD2fLGBYgTNKKCJkq0MUznMXe6C2okalDoliOmRQnyQ O5gK3cYZ0kFMa9k6X2nKNxuS/elkpWnYs9LxQvrJRoYqy90MNeE3qwD/bof/W14Cjkcp6SzjJM6z C5AowxrdEMcyYHIgBZ1owexh8EpDFA+UmILFP4AvPBazVrFIVLcZgTBExRrWxfqQu2yZrFgX8gDc 5lfC+vlBjhGiydYyRAD+oSWHeNTh8gpgASBSSgFUnEUCv3KdgrCKPMjc15jmBcUKbi9zUixTlOyj G/WISiaVzFvo1CQnPE0lHbUUVJtg57JceZNB4DEUgWDIIPu1U2yB8ubv7JhLPC4vABEwnM78iIwJ GDFTDWgBxPhDUNlVbxC1WgwjLacqCL4HmRAtT76UMkQpUjFaIPhag4p1PlQRIKMPM1nf/HSCEyko RVDxwIPYiCGOynCT/zDc5MbCU0uUPuiUKsVlPYW3PB+gwJfpUsDBEEGABCxgAQkIJiFegJIjEq0Q 9YoLa7ZSyFqgJksKjY8h74O5ioaHq5hTD2KGUxjTJKY3tgErqpxUJZpM8DUktMxt1Gqa1Kg1PWJ1 VdTs2tMi3XGnNespAQ4AVMIuYDkiUICNaEADBYjgERUgpiAF8DhDIM2rpjBYX//C2YD9FbDk6ik+ C6uuKBoiATc6nqQOeIgLdCCQYMHLajboC8129rbh+ixoHdXXwvEReTwzBC/1WUChGiIYko2tWIS7 zdo2F7fQNY5udwujvp7rt8ZzgCEi9VtKWaoQIYAtUYT21ELoJhlTjf+ueqVL3eD19QUlKCxhhUiI AcqXUiVwYB84sAPxXsRx6w0wdGfWXuRs1rfdZa0gHGCB7qbLAtpFENCuA73NCvjC9CBwgQWz2QcQ FrslGKIO7lvAxwoivIyLTANpiuEWA0XDG3bLZj9Qo+4yIAGD8LCD02ViQJygHZnaBlWehFkXq/eq lAibTqYb47dY2AXE1RkwF0ziDycOEI5JrkrcUdkAcGmoRrZEtGxC5vip4wPwo8QHtNWiJofWEjrY cXSqSMDfNpaKG9Dyf1kBTigpM8yXWHPJnlWPl5V0O2YOD99gAWM388TC8L2vuoIJZQdXqmwG0PNd luvl8jwX0JJYM9n/EGJoRKxZqUt2NG8v4QIS04Cff2CwfEuLZQX6iLyvHBKn/hNJQqg1wKJWSKm3 00lfNFrVILGwD0QQ5QKuKxCoJS4DXh0I6mSKy5q4XNP80Z1BnMqRoDpMYm7lKnG7LDF6pdDaxk2b vJJKPGM9SHri7WtC16JvNlGyZapEr0Or5zL4Xtir8M0ipxyapmSW3Q1vQhMKvTvgpGp4gmwiO1Qx GdkiUbZ9LR1caPeSsTSwAI5PlGmAtiLXYqItkS8YzJUrhT2T7Jc1l0RTJc2nPOjhD3sI9gcCiKpM p5LXfJJWr5vrN9gISmkoa4ekNPv4AraDH0d5l6aMbTIqCzNQfJS+/yC1wfOUh+ZVz1OaUQzhBFcG Mpm31Ifli2M82ZfwYbPTdYAr4wcFLnABCiKcCE0TZLncw95lLVMe/MSccl3rDWumRI0kTSlsnLqP JL3z8l68oPAPjAl6pJYa8sDmMPPwsuYXf3R7e8rsmsnYoYftwnkaSnZsYxhaNDRGkzkdQCvrU0nF s0bJi72EHfXaBUJ/p5NRyE0Wf3tylO2DBMydUh2PRCr8+w6hTQiLsSLln/s1JTCvHHRrg1IvnlQW n+s6fNjTfuOb+57IBaCD2lwOmg1E5rWlDst3ipfWfex601smzU7BdiciFQcXCL8XAMWGSUPGZppQ LNRwJ/6ROzJxbP/Ktw/Mt3E7ZneP8DN+hxGVpS8ENXQWJHpJsTTk5zLbJB5fRhPK5HjZJibtdyok 6CkOQA2Mt29KcnbM9B87aF7XYjLzACHrA4D713pR5x8GJzb6pXt54zA3ESDxkYC4QhUZ9RMvQGi/ Z0kXMIFuV4FagQ/5JGfKEwnh1Th8pgkvF1HJJCbflyRd00Qz8mdI4yXXxD0w2ILTM0LwQYOXQXMq eH7L1B5glSpI5msOYlew4SCE0CfhUYR243pehypaV4XAYG99Qn8CklNIIoVih2YFKImJkoV5s4XJ 54VOlgl7tGPIM3KOAAKv5SMrpk3ewRmaQVHc90DpsCqhFzqi9yb/S5QkTLEqptEqmbGHPVeDXlYl xIggaahw5kceqIZ0LuN0VXQBl+GIUWc7kdiAJaWJmJNmuTNqN0QVp4YqYicsqKYgU0gvpKgJXWiK hJEJvFRlNBBijhAQHShkqLJECLVNTxJBYtJpknQv26d94ReMrFJxqGKMuXYZL/dtVkVbcpVNm/iJ +DMh/NeIn4gwkIiEk6hKlVhSAiJvmliOmtCJ1Ih/oYiRUdOOlvGO8FgOzIck8aWKc4YICPBPk/WB 2gdmhocTbgiHPYl5UhQRwsg9NsSPtMGQBslBqOYZN4gfppU9/tcHI/mNu4eNAaiNHllSBMB0TyeS 5WWV5MiJR+EU/yBpGFjIklfIhTGZFTPpAwtQZYRVAk9pOyNAfcRwhpqglFiTVWiCZVwyNcBIgwd5 jA4UekwZh+GnkPHxEz4HmXxHlRs5fyQBgU2HkVfYkVimdWuWlj1HgD5wlQ1Ylmmyjp5UmU/xgGzp kuEBk28ZDXEpA6rYR6thayoGeD2JCFezbdIDQWi4FKknfki5kLqmGQ/lOVT0fZ8CG6xBZLVCe6yR Ne/hnKuiVNIYmsbHGndCJLjCNenwMreEMNu4LYeWO9t5GH1RUlcIMo13J2phMrChgLPzNuFBMsTX mm4Zm49WCpFmk882CP6UYuM1NI5UkL4GnOHjk6Xybg/5ZS0If/9G0iWiEno0Z5h583No4pA2x3Pt B3NZpZYbmSwYwisYkiYfAJ828Sx3coSdeXBWZ6Lw8yHnuSynpBZyxCsPWF4colJdd3YZxY77yZ8+ YQrcpYo04AKL2FTPQ1mGd5fHSCS/5jK4IW7UVHCOuW/j5g+F6DLv5m7Wc1b+8JyIMaV0pF8Il2+4 AXFRQyT/hmXplqZ8sxvpdhgUh1f/0TdEwm8eRWb6NiP58qbuSKQZZwrnQpe0JgiRBYsnBwjdISPf AWqSygwUSKgxklmKVZs7QxIUQAzFpJuTGqovUamWigtx2QdzWZuENZlR0wJ+Z32iGqs5Qaql2g+n oGO1yQBj6AefFEFhKsCTshqsCwGbtWqrpkAAvaSqBuQH7UJ9qxA9whqtCUGrxfoJpxoeEUCX6WKX SDJhylVk0hquy0Ct1doJ1+oDI6as62JtkaGP4vquGUas5eoJ54qsqnpnPoAAHQis8NqvlCqv81oH cGACW7AGWhABKZCwCruwClsCW1ABOEACEjuxFIsDAFCwBpuxGruxHNuxHvuxWNAGAzuyNBMEACH5 BAXIAD8ALEIAAABQATwAAAb/wN/PRCwShcikcslsOpGsG2tKZUF+LJt2y3ourbywd0wum8/otHrN brvJpvLnTa83fXiffc/v+/+AgYJmJxSGh4YcPwEOD46PL2h5eIOVlpeYmZprLwMqO6ChEgA/BQoH qKkoZ5N5m6+wsbJtc5oBAA0qursSEhs/DzSpqAwKBGatrrPLzM2ytZkhEgLU1QISMA8/KAzDqdpk kwEvBAGUzujp6n3Qlxwj09bUEgYnPxnd3gwLAWPiDgkemDu3rqDBg2PaVSLQIp48AQ1avAhQIt+w Yse8iHsQcKAehCBDIlQo6FaDh9VGBSjgbZgFHRo3dpwkcomMB5FkBTjBEwQH/3s1m5EMtEGCCpTU VIT4oaNlKgYZ+t1pFYCjwFZBkTxAkTHWhwkIwm6gkJXZ0D8Udjh8eJTsAov6FBRwkqzqTKxZOXaF 9TUsgrFll53t46Eh0nkGPGyD2zLBVKpWPSoLqndWX7FkAz9DlszMhwEnD1/79cOBBafEMpBMhsfu VXFS0cQWMtjLbCRzbiepjLu2EnI8TxDI6eVF8Bc5wWJm8gG48BdDkZPLafwEdNzAhxNX0ty59e1C OeMdE6CCgKOHJQwg/hb1AblLWPtwLdkHAUe6uevAWdpBgA83PSDCAw7MJQQBjeiwX4GxvUCgVAUk OOADMuylVQIEfBChgAsWAP8eEi9wQMEEG/gVFgUcWCjECRdQYGJYF3ig3F+ZIcEiWCX+hcAEF4AA jQdijUWAi35NkKKMOv41QY024vgiAhT46IxvSchHxgQdrPWQBCMohkQBFjD21CpVykcfZAn49wRH aiaggwP7yVAAgiIEVIBVc0ZYJ38/EBDQDzLU+aacN+ngZgGzsanDgBUSUIChIshwGwdJimViiRcQ 9wKRT3YK2IEu5viXqBtsMAEIQnAg6gQkPjnjiyXudUGOpcJKAZWX4IoEa2OAAI9o1yyVRADtOUVD CbPJN19kyXxgqANOACSQEHWKYOEHHLl5rVUHurmoAx/2GdmFAZFEQJ1dfUD/gag7UtDiq6baQ0Cr JrL6ql+fnkBvWEu2COsFP3jArqn31murVOpCiQi8AJvFCq9OdBLaYQ2stwSYYh7AgAUy7KrsmVi9 YKiBShTgZhLoMuEnhky8kIAI/Zz7sopKSHshtE2YjPMPs5rIQU6FXIoACC/cS8F3xl1gqxAvTgDU B0iaSAEBAks9nL4vTm3cvcRZ186m9ea3ia5CKNvELVpu2YEiTBTbEg1kKtsaszR1y3ISL6SMhAgi DOWnDkN94GbMdZK8ZgIG8qbyn32+CJQHnJ54whxV+9XwsJTiS5bSRUbywgWvTuBBTqqaCNQPmft1 euphARUAASIecsEJrE8g/7YmZJcN8RII9CLaUSGIDSZqDEQwh9zL3kWQECZbu1sCHaMM0+LTMzF4 nyeTIQPjii/hJzisI3ACCKFnikQAkU8Q7mV/XRDAqxcMie+SqCZRuupIAGk6EuHLy2mptWra7TKR ux+YTQkeMEDa5BGR2ixAGKhxAPKS95rlCQEgOogEIxgnPb9lz3o6iFlHyFAAFICje0r4Xqo65Zco MSF94frBjDZwAfbBCgHxY8L9Wpc/x/HPcTbEIQggJ0CHPWx3B2rBxJCigg4wiQmmyBgDUDBBkH1E CRuEickAtwQRcNF7H1zC9c7VNzIABGcoTIIKf3CCThmpHL1BQs8sxwT9Lf9nXU862tdis0Px9XB/ KzTdCVZ1Oh9wjl8DxEQB5XY+XAALIqQYwwOdUrwXIM81k1mCaxYVLi96sHpiDGGf9pTI5uUkjUhY I/rYhYDRCYEcHGBVKvPoNXIccjkEyGOGftCcoNWoj6ezIw8DqToQrEpWYTPiETsjhBgYBVgRodnF FJCxA8jgkhzJ4Ae2eTjENcGT1HPCGOsUEGkCKgHeFAIquwUOXkaOX6xqGlBA4MZ4Pilf97KX0eYA zD/ij5ity2W9ODDEd9pOmeLh1QV+9TsVTMAMbruIC7CJTr5Z9KLOWwSbnABOMIJSCS8T4X72JAPi RMhQD9jLOrHXTiHckoX//KoF1lhpsOWAqlL3DAuq+gnQDazOh3MMUgAtlchcpUFuDFkiUhoQyTIQ 4DRvK8EH5BaAAD3iqo7A2QZb2sWPpnJAZxnhGuGEUQWldAkOyOjidgYiyOEogP06HRJAMKJR5ShK Qb3cIgoRTwDyiwIe+EA/KGWvqfVQn10hLKuOZkDyBaldSitsUS1RQN3VxZHAoscJmHm2STrlARO0 IBRfVpvhOMGcfUolB8dBgNYOZzATccIHdtkE44Dgts8pDgFuCwLhHCg4tP0NG3krHIUYRzq/0Y4G QYS0RSShJ70tx06QG56jsqYo6DmMLiZgpYhV5G0uqA8Sa1u4hXBQM+it/64kkkEBhoqGqeLN5BK4 0RKMII8MGzUvV9PLX76soRUgMMAjr2EAENy3CR8oAQRdAlpGemEr09LvZPtL4T9U1rI+eAFmG4qA CT4hAWKCioPHgFp2XKfCKCbgf1sTgvM8kqlT9XBtqdkSCxCguynOsY7PcGHdTcDFmS1waK+oBDwk AKreEAGOd8zkJi+hxwYszALloYtfDHkqL4jAglFBgwxADFFODnOToSyxAVcsEleOTx7oexG54MVk MRQzindSYi9AGRA9Lk8uHokNcKS5THnIMmMYkIC6OWuEcnaDBzjAaEbPjhkvQADb0hDpJwpmDRPY QXZ/JywDhlbNkxDB2/+iogyAoNNwiab0PScti6Kx+gmPTkKM0nHhd0yZgS3Yi4wBPQkC4MMbFijA OfL2puulWg2RBlgAlj3hSriaDC/YgJcOUlkCgGbAKhjBE3eN4VaI2hs0KDQSzgiMdL7yCWI78Y4j /epmPDshQwNJAU0y4GtUgAkj9hhrPhABuEClFnkTATt3I0q00ixvOEOQDAqkhOi9QE4gWrgDKnQ+ D/XJAROHI3citHAw40biMmgHgDCO6t9IWrYsusBPltDbJZzAS1TjJQguMGuVeYDmgf3Bu2XOAZWf 7gVAOhoIMjI+7vhE5Rpfkbx63qM7MwcNCNAFtgewWXyP19PKEjVcgq3/TnNzJHqlMDeIzjtulmHQ EXwjGYYC9aYLvswR36oFgeD0iHJVnG/74VBGRDah8o5yP4bSgTTZ3QSsLclFTgPRyZWgtMEaabF1 rd9NDx8WD8yLbZE+PIkoEAn92UvZhjgfPdsFFsMKIRGHR3yc1ZC79t7aGk2kgGi7TWR9y+cDvx6G Y/6mBL5J7zamVlGahEDxAxkqJwERPBIMVdKyA84HVjHp8N3ugK6YjGX7oU71qdVOBA1+8Uowph71 ELT6EV4JlBps5aGhtIwIdHJ6APqOjHQgV+ocSAD7QBt/duLQp0pIi6B/YAEU65J4KwIle0A2SVVv ElABdbNeyNMUFxEB/y8AEKhGbswjdgi3H7MBEDF0LhmBTl1hgRX3LIugIAoRKBmoJq8UfR+gVmqU AKuHN1DSaD/TOLeyBLNyDDv3Q4MlbSanGF+hPt7zF9O2BP73AfGWBP7XRu7DHWAhWC5iIcY0gzwm BwDwetYQTQ+YUHKDexaxMW4SEFgVeDnxgi31ADCxPXsxfTonA4uSUiAoBBzkMjvjIOW0fGyVgXMg ILiBQQYiOCwYgx5XHGART4nnIuGSbDpHf+iHAOr3Ie7yA8YkV/YDhCuCeAAjIq+0hEgQeu/zUCrT SuhjaQSwAVboGWUQAkqlXTvAXeNRBkMGfS2RAd6iILioIIgGEO4HPf+8NCBl14tpoid8E4Ik4yc5 gUEWQiEXkwBz0HalwDdg53YPMCdKgCdJ1zI4JB2R8BWWJkcI0Ijtln6oQ4RKgCI/MCKndXIBoCqi 41ZL0omSd3pkUTRHeI4ToC6WNkipKAdkcAEdsGnvVQHitUxVlHsaowDOuE0MyZCGkgR/UhXVsz1z kTftpCDEITMh2BXIyHYlBwzTyIfOUiFW4TcC4kXTeCfopAMf2Ymvdn5MQE/iuATkGEuSqAj+1zL0 54RJIH7yeI5kkUuWKGv5mJM2gop24BtfYQCtuFT1sGRPMIt58AAHQAMMcJXh5gQm004e+APm9oJa dDd+YiEFkFF3gz3/cXgWzFgyzsgUe1JnKrmHpcARLQmTtBGPTUApMzksLuJ4N5mOosgE+weY4OF/ kTaP6ViP4IeEZGGUK4KUdeAb1vZMj3QUsHh1j3FlH7AAJRABJaAAJSBwZ8MbFmko7bA9cFJwfqIQ ZbmRuPEyq7eWSWAyXReSD1ZGWCQg+WGXp5ePOlmPjpgEYOGXSKgIQDKU/6cYjlmKP8mEmaGO2ggC zKkE/JiUJIYLAokS8JVvmZlm42AyKFCIi8OV6BSSh3aWfnKBd3OWpcGeQrAS6mSbtMlSKhMugTIU abWbi9mJlhYASuM5OJRCO0Kc56gImUcSbdRKhJkE3vhKG4CY/mdM/3r1iQgghfsImXSAKx+wYUiB DR5wYHQhlbWHmuRBl6/ENyRhM0lgKNY3M3S4F9iSJtDgIAJXFfLpGNS4F7zIFAVQC34CLfdxjG5o cu1GiQDYD5uCienoR6+EeATKhGzTRhNwDEgKJGChGIPEeYvwOZ8SituRk7NiPjFDIgR4of1IBrqy oZSJEhIQA58WorP4G3yTii5TPQTCHMqHN4HnCAGRUVzBHQAxIYGXEdA4mzhKfHvCpyIALR9wdtk0 B3gIeHbXMjRUeCRCeafSIOuCIi7iL5G4BDzSJKZiCH/xE45IT2NBJHjJRidCFtO5CJ43IqbSFY7J Rhj6BmSzoU0JEf8DEGMgCmp/Nm4oYJvREp6vFEPqpkYysKyR0KPEFx3LuqxdsRIf8nCzMVvRGlxv KK0plK1P8AEp8gQp9xMkoX89lyI7ARRFx3IWQjs0RzRCYHkgMnMxon9yBXQ9IgQtx6Djaon7qkZF yga5o6tqI3vBymvc9p5wkquyeWwOaxAFVGbWIAEhIKLA+qaa9LAai2KVpWGUqR7HE6cIm7AbW7Ip dmEEkIUE5iUWa3ska7Iw2189lrK6cG+0B6ItG7M6K7NswBAD0BUiqgc5u7NEqxl35pgWK5VFu7RG SwvgkbQHy7RS2wxGEAdJ0AN8EAZau7Vcq7U/0LVgKwZTO7bM0AMCQQAAIfkEBfoAPwAsQgAAAE8B PAAABv/A369HLAqPyKRyyTyyLKlUTcmrWq+/K1ZYwZG+YJLX9rOxmui0es1uu9/wuHxOjxPreGHA RWMoXnk/Hh0qAoaHKg0bgYyNjo+QkZKTdDoMBzQoSD6cnZ4/nqE/HwMNh6cNAAGUrK2ur7CxgQQK fQoEQqG6oLqcPyENhacCDS24ssjJysvMgXyYC7y9ndK6ICMSwwISIx7N3+Dh4soJlwwWBdOf0wEA psMqEghMHwUO4/j5+vtoBBaXNFwE6BXAgYgHA3ttkCAMVYUmGWiU+MCvosWLzCJcOnBAhq4AKBjQ CPhB14kR71ANALTkQ4QVEzGuWSWzpk03CWhwpBEhYaf/Bww2YlgQql3KQ9y80cuAIeZNJShKPPhG YQKCEBXmPd0KpwBHjgxEhHq2c6KnCSoaGoo3Ac0Hpk65/ggQYYaIZicMFJKgYYDcvzMj7oxQklMA BRsP+EnHiYCBbMMaPHQLl+Jfuhh04MVWqC/gz0185PzKIEGnACUSL+7kTluDlWneNrUsF7NmZieF vQbNe5MPGf/A/um0QOfgwhS2DeMGQo3suEc+0Hb7YZV0mgEIEKiu5IP26Ui4R/8O/ohtPd5fiEfz 4gQHqxQ4gCiPJMAJDxQQTOBwwrteQ7spcQIIFyCAwAUgnEDTEe2B4MEFF/zwAn4HnnAEASDkt5+C Stjn/6BVCFDgAQgs9abGaSUYhwkKnfjTh04PcPJCC0cJwNYaz4H3QAkZ0IeEDCVEIMMLGfRIwAIR KGABjwmwJIILJVhgQQQuNHlEAVRSVAAKLiS5ZAQL6AAeZg+8kEAGUSoQQQYL3LMEByG00EEDdNK5 wwAVcNDhBAA8VmcDIwwQwgi6+RUdn3r9qYIBAGxgIRcdENPXBS1IUOcIFVAQZyJ1djCAnkhMQOif dHoawjEmhkaciucQ0AmWB0jVCTCuVbAgZbMl8UIJK/TYxK4zuPBDAedkoEAJKOjwpAUYRCCCRhEk m4ALFsDkpg7NFrCABTQosAAKKCyQwT8KoEAbXTQYG/8rCiKIEFUf0SDxQgVzMmQpnYWUCkBzQngw gKWQSSAwwCodccG/wXDaQDacGrDIDwBocMgIHWgQzFoN7LCwwMIk0kGER0RMKsMNaNDCo6kqEYoM in1FA1G+BMAdJxTsoBYxA5SEY2VK0LJCvEssAJOW/1iAEBIEMHXO0VdG0OwqDxygAGIuyHCrzDoo 0CxLdAWVgdX1PcDsVEK8MIAGkDUAwwBsG4AUoBT8cIEBF2/DjQFu1xigqBcz1MIAAAywwyF0AkBA BSklsoMBO0Bm4zaL20x4CwzK+XfgA2BDuCopJ6HLB4iR1pEvutIYmQEnkB4bz0o4wG0CS+SEjhAF MHv/lxJAMUB2Eg5gYIEQUS/NngsY+IouYUygUPwqRq0lQQXeBDBBC4XEAygCeaUkQQsIjAjCBP8W fIHm2xiAACCHS26pCp8ijlQLFJwgquMqwJ/hfzZ28OgHFJBIAE0eoJ4huOEj3kyjOF/BRAZudQRa nSIbFKCGc1iHO0zc7ggOwMRthnUAC6AKCUCZnRIK4DvgYQJ2sXmJJjCDwiVgqyc/SI4wJLCIF2yg BcSwUwsmYCEHEgMAJRLCByrguN2UYoAtaA4H+mQ9CRggTxRxn41U0BYupEQRRyDiWgRQRblVYAAt CGOjtLiNERQQNNNwQGK+4iYkDMJxAwyBKFaXKybI/253u/oZErxyiyUARQEFWIIMSviDPwaxCSiY QQTm4rQNKuGFq5CiCkZAgQpgo06M4gBNSPEO5izBMWkDwAdM90MKDCCHGthBC2LwQUkKIG5CCEER u0jGQrSFUjksmQYsFqkBmrFzuZjGrtbIABhG54ioEOUccQUdqPgukD9wwQqQd6UOfvAIf4RmEgb5 u0IWkw2JLMEqGtkESP5AigIgxMLoNABH6QqZnlTCCx4DIMPBwHGNu1cHAEABBp7zHYWA5TmLqJWB bjF+dKveCAAQgjg5joDAVAcnEJhABjjShwNE3S7o2EwlEA+QCcBAH/doTT8uRpCEjFpH1BCADPSK kf+ZKefTfoAAhgzjiUop26PaIbEBVmBM6HxNAM42jDvx0DwOoI0rBUpGYhS0lq9EQE+5IdAPACBg v0yZRDkRvARKxDIeIN8AOxDBXnDUn0kggNOUdIDdVdODJgUkSrsZtXSd8QflOMA9zsMEc5otcR0I gf8yVAEDdKCKF2ic8wZwgRM49gJXLRgFOvDQFlyAAA1CwCmBaMWDZpGgnz3oBqY6ApCNIrJlvCtX tuoDWqxxRac9Sjw2oA6OyqAAuM1tbo9Bi5G0kKRwxd1JlcBNE4okAm6V1wKCogmYOjIJ5vwBAUrx 0BHgTWMDEwACVrGBeLytAwbABkMasjeNIQK81k3/BEOKYaGlhhZAT4VMQC+gnPJVYAMORUpWTcRa TgimohOZgN5UUVu3vIQGUkqwgvUqxBJgQCBL8Epwk/AABGvzRyllAI8wES0H4FYGy5LI7uiyggs+ cpoLmtecFpaWFltvYScTAgX8ZNN4CCxjhEqLZ4TAARqxuMX2wpcKFlEBtN2Llhvjy1M3RqcJGGVh NtKlBtJy4w6o9ib95YQIEiicwx3FidUwKxpQsKYImPnMZ3aBZRbQlENeyQIjpbCGrymEQSoAeAzo kQyMZYEOKrgEIphO15KLBBGki4EnqEALRiAptIG3Bfx8QYo3MADG6VIFHWjBBiJ2CAAkQbOG5YvF /zBtgAHEQAZWtO4ILNvAu+GNqZMML/xGcUNC7LIBnrqqddeWqizLKDguc8GMHvox1gYCBTpBNT0e ALaePaAAaP2ADqAJlEUeQQY6eMADdOAAOgvBAUltAgGezYQAcIACG0j3BPrnZvOcAN3qvgBF8lMV /izh3RNI9wYm0NgkeGAC3pP0Ed4tHxB8UAYictALfMCgC+R7AweSzn5AMKRe+9oHGVgjBlBAAEI4 72HGrkMGaWBiSVT7ysBMuSwuzgkdqEiDHJDcDxe01ToQIEVAo8TJVc5zcLCc4f7AwEgwcIACbKBO JgtizefQUkWiHA8vfHrPp/6In19b29p2QAC+N/+BrqPsCBKlQwAK8ABvR4IA3aa62mPxc4bP5QTa IcAJAPECzG5nCUtfu973ngarx9K6eOvATyMA5yVdGOwF5rviFx/m/h4BAdugsiJGHpSN4z3xaW0u 4zdvcZbzmLKIEMAFXO6yBV5+GrHDQBs5z5UP8FsOAej3Z9peNlKupQMvUB5pROg5zAuht9ZmPRoS DYDiG1+gzPDADjzNhluBQAI5m73n59KaBxqASC/PBBPCjoTiBOW5wve3pRwCjmtMJjYAKOhpQ4BW m9D+Bwu5mWRcW1Fj9h7115ZSxjsa/n6pQJTScR3lhylr4AEaEAJa5XcXAHoPNALNQVEJdHiIJ2b/ QiA0C/ABvNJCAXBbTNBuc+FhKecBEsB8+GB+awACWMRffncClQIPDYCAPwAca/Qy21dgLHMAuFBh f6AHQVIeLbV6GHQAwiJtC1CEKKBsErIAqOYALmAudVaERah1uZAAU/EAUFhyZSMCUJgA07ElRvhB BBAuC2AlTCCCJChPCAAAFZAVQfQCIYB8QnAB7BdDIfACblh8IQAqSVBJFcBQFmKCv7dpa7gBLAEC RAQA8LEKBqIrWLGGXTQXi8gBfdgoHugKtMdJrhF9FZh9JeCBBeZS8YIZQIMCK0BoDnBoHoUBCJFx x1ICitFcMrACCbAAUiMs2LckUXIAGYALGMgm/7ESAalRAheGAhxxLAogNWQjNrj4Dyi0ZbjYQeDX LyPIBBRAKAbQAnoxAk4mBCAgeEpwVVEkeHjDNjCwA+pHKU6EjYz2hgT4AyCwA5m2aMXQHBUwOOjF OWG0IBtACNf4GKwmIWBkSX+DQwaQU2znd8BwM5hmWsMCbC1DaMFkVoZ0bSUlXUuSBC2FARaVVroo IShQJjKjjLggA91iAWKSHTgnA9WRNCsASKjRFEcTAAnQkXNBPBkAkh9QDpnxAUuikh8gAy5wF17x NaPAhNEoCM+zBEcHP9vxAtNzgKsQVucXMgIQRbhWAccgAwOgAkpBAZOEAE3pAZbEOJMhiRwgHf+J NoL2UVMV4CAWYjYtwDxFNgAUsB0EgAAo0RZ/BT+WUY2aCAvvhxZwBCAw2H0vNxSq8hFOgwIB0JiN KU3CIgTK40hRQ3glkARsBoQ0sWVTQZJtpQd80EI5+Q8ugAtRck3LBQiGFpnf5ooK4GEHEI06sAIS WIYC0AJruIb3QAHQd01/pSeAiAQAUJXndID+5o0n0Q1KwJuSgZE0AUargIIPUzZso4ipICAtsAO4 sJV6KARHxy+v0HYMBwL0FBmwwZGq0Yk1qAuWoGFoZiy+o2xeYUx04UF8sEEEkGc0UQAucIwRoAMz 2ZnFcyU0+IEpIhVCpACseQQ5EUin+Xt8YAH/XDgsDKBmJ6Z5aTAIAjACFKONP3BKBnkEIMA+7tiO wkmc9AKetedpwKB+SFBkkxEAmtUBC+UBABCXgvCC8lKdP9ACMOBtFKABMUAKlJMEE6ABIcoKtPdX 2iABHdCdSBASFQWREdkJGFiSCgZntcCaLqA7eBYNBCA1ltGlZGMJQsglUvKZsdhCD7AC91AATGEB IrAgGJhzkkkDBfACCjoKKNBnC4Aqe9AUVFgiV5oBH2l2/jcAIzIidRco5QYAHVCiUykEwxlFDlg6 D1FpHkgBzVmcTxQnNDoAUamjDMI2PxBzk3pMAzBdovppSAqYtIdOqFCY8lQLLmOnvuEJyhMB/wUQ d75aALXgJmGaAUJAeMcgNJown6ugpxbQbGLjpbG4QSKgesRoARyXBHUKFTSgHRawADuSLnQWAM/C Ed1qGR/wLlLDmGWYlG7kjUwgSy8QnFRpqSoqIbjZo0W6BCaIAKlwDG7YF6NKq2bjFzXjosLZAazK QFKVpJEgngxXUzezDS1QiT8gpWAxYSpjpXdGpXg1Uz9QHDLQppoXpgrwAWyWjCvwXMvVmSmLTQhm AaXZEiWAq8imHcd4AMjVfnPxAiLAKxCmBwSQACmCoW40jUjDa0wwnFtnoiGzA/SKqR96fdSoApmq P/JSagG7o35xDbQqL38zsAr7qq0gnqcqVv+IoAJw2B2h8xVYOIE+sKs6+wMRQAO3oUbAWHSGaSyX KQQiQJtJEKAx2LK/xxFAGB4zq62BtJhxmwQZgIPdQXjreoZCIDj1KgQnsbVMa69Wdk6X6rUPQURp ywUa8BDYeCuk0KoekILU6RejZAD0wQEveLphy7AN+3MEYHvkpwajsRPEqio/8A8xggYuFxOBiph7 xC00sDsimwRkGriO1KXROKfZmgTIFkiG5iu8g2oMtC24wEDjErlKcAHQd0icFCHdKLkcAFGWVK8z 8hDdaAxKUFPNOQAdoKKXm7Wl2qr8yjlIwII7YCE8igQLC6u+1jyugTproKcbcQ61aR4LMAP/vZsG L4FCasR7RyA01CQhxygC6DOT0Cq4v4dzdzduhLcKh0u9eFqTTeEAgPCTKysD5bIdHxA1C6QDgIYL L+ByuCqNkuudr8EB6vECHFAKMOgD/4IAFBEA/gIoT+u5QiBgltWUJxACmEa1MbQ9QPwBIHA2rfoB q0YiFAG21KcBAOABQTxjEqCXAfx4YhueWfYLNgUPOxC6dpQYNPBbrXMJhbsEatRHqLGgV6IAJQes TZEkUgOtdpEE/KkTZlYtcjoKe0q9GABNMnkAhcwrQvgCWCJSwNgtgeQACrACUxLKJWB2qdvDQoCX xQBG1+N27kgjgEO/gaMCUbQDITpPJDhj/xpQatkpGROwT3PRXaucTqtGE/y6arCRj0IUAjmwPWBk MrA0IzgqwBoApWPbX14ZscSQqmiAGsaBikvQdDvMBC4wA82VdnxMZzkMhQ4gA9d6JOHqhUVYdgxa uA5wgUgzi0UoAv+jB1ZYhGQ4CjoAhWIibm8obmnoiF8XiMWXKfzzMJpSHhvAkC/AhwzlDW6ohyAQ A30YA++mfpLIUNWxb0lwAhvQh5lSIgFA0v5Wh8jAWnkxmAACv25gpophweEBJQ0cYTO7uP330yun DkyqDfFAx92cGjtBtGIH1Ew9DuqAUcnk035kHBom1U191TXRCxPwOE1qAIiaQjpxCUiI1WJk/Reh wAFmG3pGvQZdxQDjXNZwLRPUgLvJVActpRNfFdd6/RQ+YMAHvNBxoFJ6vNeELddQ/UDTKXZMQQMP ZtWF/dhpUARGwAghEAaWjQMDAAGBcAM10NkioNmQHdpwQARBAAA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_home.gif R0lGODlhNwASALMAAMDe59/v8+/3+aDO2xKEpSKMq2Gtw7DW4VGlvXG2yTKVsc/m7UGdt4C9z/// /wJ8nyH5BAAAAAAALAAAAAA3ABIAAASS8MlJq7046827/2AojmRpnmgKFg0jNYaEHMBQvI1ENDnD 8y4Uw5F7OAAPxLERENwcjlgD+pguAICYkCg5PpqEx3BgdAQIAuo0qBpCoUhvNz5wHAIAR/XtYJvG DENIAgESBXZGDXUGeXsJgWFbRV5TLXkuRAoNBI1Tjww3knMvaQEIXUUPnXypKq6vsLGys7S1IBEA Ow== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_currentissue.gif R0lGODlhcQASALMAAGGtw8/m7RKEpd/v85DF1e/3+aDO2zKVsSKMq1GlvbDW4UGdt8De54C9z/// /wJ8nyH5BAAAAAAALAAAAABxABIAAAT/8MlJq7046827/2AojmRpnmiqrmzrvnAszzQqEAwDPEAj 9Y9FY7gLDhtFxBGp9PF2S+Sk2VjwFAxD4oHAMRoCIM9Hlb4CDgLB8WCw2+yGI4AmPOT0dNAxyBEW Dg47OW1uBQx2EgdoAz0OBg1YAgUDDQQDC24SmoB9iC8ADk4HcJtxDlYODHeoD6p7TnsFBQiEEq8V gD5uAKQCgAwLAg8CmqW6MnJWE8aaeAMOW8/Re4GigKE5q7fbFMgJBYEFg9YMxW+c1qIvckXDzacK c8Ny8gHDgAYLCwiAQoHdcHlbRywBgVmKGrhRiI5Nvn0IXiCYlSBBgAcGRIEbwOqfgY5yXD4+XHDA 3wM0AbtJEBASgYI/CQZg0rFgDYCMDTbu0UcSxiIHBT4KkDeHlLKTgo6iAQConMkDAgVKaCqqATQH Cg7UClSJGNEApKhKrUG2rNmzaNOqXcu2rdu3JiIAADs= ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_pastissues.gif R0lGODlhXQASALMAAJDF1e/3+RKEpSKMq9/v82Gtw6bR3c/m7VGlvTKVsXG2yUGdt8De54C9z/// /wJ8nyH5BAAAAAAALAAAAABdABIAAAT/8MlJq7046827/2AojmRpnmiqrmzrvnCMDU2tCJJQ44+g MAxAolArUoqFx8LAMCh6v2CCtnhQH8WaFQBs8FALB4HhCOAKDkfywQgAGocGN+AAUsjuMKNhCLDd cA1hDUoOhGVADAIBBHIEVSmDDwAOVQd9BxJiCAM9EmQXdVgOAFU4m50CkpKiEnoLOF8nYQYLBw4D A2oGuKNpBAmfDqEMVgRppL5iCauGD8iiZGmKKmG/CJOkvAASAwW8BsLEEwsNx8He4M2HBwsLwQ8J Pw5Pkc4TjEABfgQKC2jh2AyrEOZAAj4IFpAZ0O+fAwO62vFK4qCdO4UFFlBaA+beAwQOL7BlQ9Cn jAEeoCogY4DgVkVsJQOcfFDgmBtN0AZIaySjp8+fQIMKHUq0qNGjFyIAADs= ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_resources.gif R0lGODlhVAASALMAAN/v8xKEpe/3+SKMq5DF1aXR3WGtwzKVsc/m7VGlvXG2yYC9z0Gdt8De5/// /wJ8nyH5BAAAAAAALAAAAABUABIAAAT/8MlJq7046827/2AojmRpnmiqrmzrvuOwzErwyPNi3ETT LLZEoVEYSHTHnSHHmAiJA9xsN+j9bCaGA9BwIB5aboMQEAAWBAAj4fgBBMa2RN5tAByJBxux4Id9 ZGZoaidaCw9dYA6HEloNDDYBbzZaBQ9ylw2IDoqHkxIHhhOOkA9YJWEIDgSKDq6HXa4NAZiZtrZ1 AnC3ja6vm7KnJI66B4oFDAxGDwcKXQpmEgMOlph01NQS0RIBlcnLzc+Fi1oI3dTJoQ0GDAQOS6sM XU1vCQrZiV077sgz3gzq2LnbkWXRA35afDUYEOvMEQFb8jBTRc1GogHFDkJEkMxXG4auEBzCGEmy pMmTKFOqXMkyRQQAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_forums.gif R0lGODlhQwASALMAAEGdt+/3+d/v86DO22GtwyKMqxKEpVGlvbDW4TKVsXG2yZDF1cDe54C9z/// /wJ8nyH5BAAAAAAALAAAAABDABIAAATI8MlJq7046827/2AojmRpnmiqruxVNHADPMnAIPNDxPku +QCZ5CA0KBiMRQIFcAiQhEJA0GA4Dg8rQ3DNOiTWR8P5MAQcjWxgUU2fmu7HwDEzC7wPOB4/duwc aA9OBwVlTICAAGFgX1oBAYWLYWM2AXNpfU5Lbw4DAAAGCA6FDwIBXqIDjKtjBU56DwUEcwiHcU0M AAuBYVYEcg4KB1NiX8J6AgoABJ22FAdcAW5hUgEJoYAMS2MTeghnlgYt4+Tl5ufo6errHREAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_aboutus.gif R0lGODlhTgASALMAAEGdt9/v8xKEpaTQ3e/3+SKMq8/m7WGtw1GlvXG2yZDF1TKVsYC9z8De5/// /wJ8nyH5BAAAAAAALAAAAABOABIAAATo8MlJq7046827/2AojmRpnmiqrmzrggiDSAVjJ4K0DM0A SAcGUGgrHia1X/JRUDQajNwq4AhIAFWDY8AkBBgNxywsIT8dhIZighW2BV6GIvBTIbbix3v7GDh+ cFZkD4MPDg0VbXoODFgNADlSKQMBBXxYDmhHhWYOZZ4Sh4mMi0JhmQ2SJwIOBgwEDgJYPn47DgUS AQSEoIWiFIqKDwsJYQkqCYcNWgmzAGELjgAKpH4JCF4Tv0itAH4Hz+DURykGBhKsBphoQg8IVATt An6tC9qIFQfwawWnXy8AAwocSLCgwYMIE2qIAAA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_contact.gif R0lGODlhVQASAMQAAEGdt8De5+/3+VGlvc/m7d/v85DF1SKMq6DO2xKEpWGtwzKVsXG2ybDW4YG+ z////wJ8nwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAABVABIAAAX/ICSOZGmeaKqubOu+cCzPdG3feK7vfO//uYQhEFCIBo0A4iByOBIQgAPi rBohA8dgJCQqDlUnYCRllqOIQINhIzwMhgf2EXAUBMzHo0GVEx8CAQYiBQ8FI25wDwsBbgVFIw4P Y5IAAHQOCAI1Cg9TEAsQd1CXCBCAD1lyInQjAw8IqRCdn6FRniWVfVJvY1A0uiOtrAGndgJxwsUi CAUHsLsll5+Rk7sHhXqDNAwPV1AChxDPfJ6XesoiCQ8EDgIPCd3fItO51sFShbYyBwICAwMI9DEA IIA1XHFWnVrWjYgbBv3+BaSHi0QnBADcgEEwoOADJjQWuBFgisq7AluMJ0FIUCgdBAICV7IDNbJk vRIGThoJqIdASiBAgwodSrSo0aNIk+4IAQA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/tn_bt_sitemap.gif R0lGODlhSwASALMAAEGdt7/d58/m7aDO2+/3+SKMq1Glvd/v8xKEpTKVsWGtw5DF1XG2yYC9z/// /wJ8nyH5BAAAAAAALAAAAABLABIAAATX8MlJq7046827/2AojmRpnmiqrmy7AkMQMI/S3MCtF/Y+ 5QCJoRF8JBo0ia5ReDkCjQHhsSA8FYGDQxBIBJ6yxKThODwQ1oZk4HA0Hw5CwFpEkRdBhOQ7dhT5 FmQONm1qCA5sCxJPDwYOaikFWm2KD4APZH9tbRRkMQRsagpuB2ZwAjCDLDlaYpeZe34AdZhuZQCP DwIEDQIOBnBtvCtRBgBfBQm+RbCWsgB6Sg4PDMaPCVsyjIwtBr5bwF+ctZqbdWQ/jwsO0b6HAS7x 8vP09fb3+Pn6GREAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/ln_bt_subscribe.gif R0lGODlhgQAiAMQAACWNqAFYcAJqiECJkYG2rPn8/T6asMLau6DO29jr8LzTtQJxkQJhfNjpwgJ5 m2ixxlGjsit6iWSqqh9pd73c5hKCoe/1x5TDsgJ2l0GAhYS/0FeVlUF6fgJ8nv//zAJ8nyH5BAAA AAAALAAAAACBACIAAAX/4CeOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ik0iQhOJ+ET2fa ORkIBmr113Fqty+AM0u9ArS8jsRzcGqejji11DF4CHHHdNc5eKp+eXMuHRUeHg0VeXaCezpdHgYY GAuTlnJgUnV3DhiYOVMABnF+k4IvHQ6IHheWjHl6jx8EkQu2AraVDR6Ydnh2h8GcABbCh1kXxh4Q DrvBeMWTfsaJDsnUilqqELsDtnaUEMoWBgCIccAAeqxfI6m0ClAE3guli5x2FwL7GGwYtBAsCUQk sAIADH4qYAAAoJ6HBQL8QNyXTBJBSxU96enkYUAERBAHPHRYoRIGcQQw/+xSeK2VOHWfRHTAAExZ hIgPXd1ZIJIAAwb72CyghWWAgQElFwjNlUsiUz/7/PwESsvbUlu0DJiM028AA3gCREb1gMtWzwVr JCxoQKvBggtuTcWSSSnCgAEZ8iroiLPsAl9h7wSYykbAhnE3C+/bZwvqYpw/9wYY/JWvBwsHMh/o hmvggMl+Nohl4HhfTwEfFYgcsHcA27Ia3VESwGDy5KqkyTI+3dN2ADY/7d7N0JoB8KmLpU7NXVuy bdyI7kofQLszpY6TP1o4/FP5z54/dxFowOBwsghAbXmSDbH2c+zKTd9hkEHwZOMHfL/3evxncg/L MReAc7dh54EC+lFmnf9SnxW4y2SSTdVbALQINsEhDShYiQPuOCCBZgqEaIEFtdFygAKZiRfAYRaE mJlgG4QoYzERBOCHi5lJIMAuE1DGwIM2soGiAiPWdqOMJ6LHGAaGeGXbNAWemKIHGUzGwSEcQMjK fZ1xKJMDFUyXVwbuBTDmdDVOkAEHZzao5pgccNBjAG9mIN1Ndy0XlpNj5oXXnBPEySabGUzg3yRh LvDTZG/a1qZHZa7pm5y2ddnhJO2VmWCAm96X4Kf3AbWYnqPqV9uioGqIaaaogrpcqr6lhwEYqXQy UauxcpprgK+6Kuqov+6Dq66bimrSbMB+yutUsKY3lya2ArvostRWy6z/bQE+9lguwlqrKXLW2TqR tD56W2yXtKayqrbsPvZrsO1W51918fp1y6jtAqUvverlsSq3tMFbb7y2PAttJ5QwZS8ui0Hk8LiM MaXww/ZKLFDC3E708C0by+XvxRJz3HDIFW+VycGWqEcJoga0rNWxlcSM6cUJTyKKQipbYhAsCKcc 87GUaLWyXFTsDAvNM8uM9MUxuTPF0Tw7YEABFFQdtb9X84xAAgkUABPPBlCgBxVXe5yH2FF3gEAW BiDwRdZcwZ22IyZ8YXcdFHyhwQNZALB3BVNU8IAGZ3zhdQcPPNABAIozXkcCiVMxOBmCEz7F3llo MEXilgOQAAIfOL74/9+XT3736e3UYEACGmhggAhUv14AAlWLULUGBZhAwecPiBD2B79PvbUGHzzA egGvV7077BTIbvvnBRj0OfAUfFDB7LV/QDUCuSexeuuva+871RR0Tz7yJFRQjgasU+/+6h9AUD0E BbBegfb3h9+9+B9QAMEHCUje64KXAOuZ7377O8LvSNC9qbWMeNrj2wMAQAIARK941YPfAzJYwA0C L3EUIJ7XKlA9/vGPAr0LYP8GyMHQmQ92SljgCPbHtQSUEHdcux8JuFe+/1mwaxmsXwH+N7XyvQ6H oDNh98rHtee5D4Bdg+ALk6C+EoTPd1cMnQF0aMVyjEB9orCeKCgogiMxjiCMvhtB+Px3xSpWEYtq TOMS5iiD5tHxjnjMox73KIMQAAA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/ln_bt_donate.gif R0lGODlhgQAcAMQAANTVqvHxwbm5lI6smO3tvnq3scvLoq3PtsLCnJa1oOLitfv7yTaToy+LnKqs i7Kyjvf3xqHAqUmdp2WtrSGHn2iloubnudvbr6y8nl2bm+vyxYOhkA6An/7+ywJ8n///zCH5BAAA AAAALAAAAACBABwAAAX/4CeOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikUngoOJ+FiKZD 7Syvu07BM4FOuBDIgso7HKpWLLCz2B4ChDjBwyAExOMclb7oV9U+bG4KhIR0ChYMHouMEhAWjJEM GgsSkYuTB5ceYYqXE35kgDAdEFsRAKmpdAARXHFwigEadAFwBF9vd7a2uRBzDIQWBJoTvASyYWNp oy2lpwbR0XQGCR4VwokeFpAM3BYKbgQRDBIM5xweB4YMqRcKmgXf2sN3ec0tCwFbCQgIBgAM0EEw 4Jo7AIpWtVNVwUOECxwoRJgYwRIqAAP/tfJA4Rw6D+8s3GGGT4W+L/00/2JkIKBghn/RFBlAkDFa wwQCGUhDkMHDAAE0GwgAWs2DhAQJBijFCeCCnQUlWejj508VHQEbPGR48A9BAw8IBHgQ6g/BzaBl BfQc8EBsg7b/rFUIOxTovwsioUY1GeALhQYev1Z4MIADhwaIvwp1wBEuTw8bBChOnG6DgwcUxiLe gMFw4sRAASgIoHcvCn2tkiagGMHAAwcONmxQqlTAa9kOBESLkADDgweyg+OGHXv2AAwGMAwQPls3 gLymU+izENBftFRhX/+260/A5d8wo2XXbvu3+bpExb/+ThQv6einA1i4MFOaNPRErdMl2vQCfbpw 4cddeDOhB5NoBIgB36UJpRCgQED2iVcWgTNZB9A7hEA44YYRRshhUyJBQNKCIpQinwIXqJKiKk2x 6KJ/iHyDoosv+ueOfzYCdCFeCd5D4ghsQCAfOIUUyU2RRnJjxzFHIlnIPEfKaGQcyoxIIhULCHmL HLDYwiWXvIQhppZbfsnLLXB4aWaVVl7JRpZjjglnnGL2Yeedc9KJh558LvMjCmgEKuighBZq6KFt /qnooowaEQIAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/hdr_navigation.gif R0lGODlhgQASAMQQAEGdt8De59/v8+/3+c/m7RKEpaDO21GlvWGtwzKVsZDF1SKMq3G2ybDW4YG+ zwJ8n////wAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAEA ABAALAAAAACBABIAAAX/ICSOZGmeaKqubOu+cCzPdG3feK7vfBwEAh0hQOgZUQOAMggxABC0x8NB UzgCI8ADcOySAtIHFIJ4HGYCh4MpkxpGaqzXqwg/gompyKBWM+MiA35pVCIBcX4QA1ZqCgMQAgxS CA5FiYoKDAyOIoSLDpxzLpILUlRSDZB2UkV5ZxAODwuwsiJlq1gGqwUQDbhgd00FdgkisQ/DpqIu Wg4HyMBFAgaPwApkD8UDw6nPXLoPCodShqm0DwQCZQk/i+QCw1S+D93ICg3DXMssbsBaDyMMIFAi JRe5WPryUMkzJtYsTAcA5AEIQcsrCJK4kBqhTKEILQz2rRDACsLELYrywiw4cOsRgYIlIbiRqQfC szMEhiUYmE1EqUIVxQR99fIBlpk0r4lMAWxPGCh1CjyKxUuElFJjihaREnLAT5soh1qlN2LYNS0N kQ3Qqsro0hSxivlUdkxNvixSCjABN3dVKi0LHEjSUxTAFZJuyxQQPJNvLymP3p64CacghJxSDnwV MRhoXBEENAMYHATcg8Fy/qED9ihJmAVvaMl1KLlGgMgxzA14JleRHBNrUwggUru48F1FjCs/ok6J YTbLo0ufTiMEADs= ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/hdr_sponsors.gif R0lGODlhhwASAMQAANXH3wJ8n6C0zw+Bo8jC22yivzePr1GYtxyFp6250yqKq7u+10SUs3imw5Ov y4arx1+duwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAA AAAALAAAAACHABIAAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wOCK4CgYHQuhcmkrDALQaIJJ ra4eUITx8LR6vyMDtOQQGQyNQ2DwGC24awhBlDg/1GwRoYDIHvR8UAxJZmgCDAUAh1EGAmAzDFAG DnMjAoxPAXMJTwgKUH8ADVFRAyKfWhAIBgAEnwNiAQh0UJkNDqAFkY6PMZykDFMABVBzuAGOfawA agEikQiOn86XAWUijnhzWMiigkYLYgojCZW9MAQN01BJ4thQAtXXxM4AfaGfrAtRCgWEUBDedcND otkABtfO0XgDJRFAEaOc0RuhZty+AA1aNRThYN0AAtV4cZvThwEJAnA2mSp0AaGAuYgNqrUhcG9Y MQALniTiNuWYI1574Mk7FUAflIx0KiVQttJFLAUGpiFIl6vPgCTVDDgJoGAOQQAQxgAIgHDRRwKd CryawnOEk5gPdDZtkTLKgTmRMskS5s1upZJEWS0lpUCYAL0GhH0VEbZUwLkuEsTjC+DJXQGU9cQz x2JBPEIkPreIxwuyDShtTKvWcQb06iUhAAA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/bnr_for_elymphnotes.gif R0lGODlheAA8ANUAADNzE2ZmZkx/M8zMzFlZWUBZM1mmM////0BAQDN/DU1NTTNmGpmZmdnZ2aWl peXl5fLy8jlGM4CAgDY9M2C5Mz1QM7KysmPCM7+/v0NjM1OSM3NzczM5MEZtMzOGCpnJgFCJMzNN JlacMzOMBjNgHTNALdnsz42NjU2mIDNsFlmsMFyvMzNZIDNTI0l2MzNGKWazQPL57zOTA+Xy36XS j8jjukCfEMzcxICobHO5ULLZn0B8IjN5EGbMMzOZADMzMyH5BAAAAAAALAAAAAB4ADwAQAb/wJ9w SCwaj8ikcslsDgG+qHRKrU6d2Kx2y31av9HsJKMx9M7otPqsjKx7HaL5TX8biiWSB2z9Qb9KFW8F QwV1akYrahpDImsRSG9JCVULXUVQTB2HnGg/AmuEShlrFBNDkkkcI3w+Ca+wsV5VTBsQEgEYA0II BwcIPwQBDScBwEMNGAEWDUMBCkIKCsYEBEIE0z/PQgE/CNbf1UIS0MHl2t0/CgfW5NfW3tXWADYw KK0+l/r7/EZ/+GD6CRyo5B/Ag/kIKlxYECEthhAjJjEYcImiUh0q6AN16I6SVEhSWPHQYgvFNm8y DJlQoKXLAhrWDBHUiY4AIyCNUKJiSd+//y4VWmYQQLSo0aNGNTqJgPTmJ6RbSoSYSmKB1atX9/Bh gmAAhAEHMPxw4EAIWSED0hGRcMCrBSENGkDY8IMBgx8H6t5NG2BX2h8NHnzVtsvuj78OBN990OBA M7xlET94UDbADR8fPvioMWMGjVYSQ++j6PCh6NOXSJdGzXp06TCtY/tEKLu2661MKlCoWSeJITog hszhbUfIC1avE/rpo8SRGgr9YqZhNPyMqSQ5i7CwUmI2bCS/ERXiTWTCBTVOh4BYoxKnTCQ7p4To l0mJdDVxknBMI2QT8eJEZEdECVaw0MVJTVRQ3X89LNiDKEuElwYkPwhoBAcLyPDacoDY5v9hFqqZ lsRfYOUFGAYYPHaYWtzsQkQAD/wgQWFl/WLYABsMsyJehGnTzI3dHKAAARLIyMAALpr4l5Dr+PhD Zj7EYAINKoD24ZVEhAgQlh9q6RCXsXmZHJiiiZmcFGTaZiY+aXq4ZkVtqnlmnFe+eQWddX6JJ5Zv 7gmmmfqw9NKgLy0R1KCshdACVoxi5aUTEwhwHoNsJOFgDxecIsSl/3n0AwcibcihiEhUMCmlniCx Wx0UckrcHauAEcussGRJqhH+LcJPBKeecR8a7UXy3hEcjMTBgXdit4YL/Eh4BiTO9pCee+IdQZoH /PyhRLQ9EMFtdi6okekQbqjhaREWChH/nxQkCDTCtm9Q+MO3w/6wnhogHHVvGtehW28R60bR7m1L rJqGCEvsl+oPrtYkrxDp/rBAFdimliwSvNqRgaZFKMzGBAZbZ8DIJJdsQK9nBFvhv5hYkcJ8IN56 RK6o9lBuGudaukZ6ERunlaghZlEBCBfVfEbOza3hUc9EcMACDxoe9KiffLJZiy4WHDNWWWMhiSQ8 vFgwgAXnMOQA2ElwfTYTfS6BQZHepHOCBRacMMRfRBAQIzdwyUUXA45BIFiRXgnWGDR59aVN4IR3 k9hcgAX2FluROT5ZZYHj4IMJJsSQg5VKOCCWN3npbdcD8OA9RC/gQCBMjDPqxSOQii+JeMAGuygO JF7fFAmBA2ILoWSQ0iQ+AABQ6vBBDTWAvoQw5RBwzDfXaE3ENGhvow403UgTDALUSx/3kPFs//07 vBiTjjjiBwPPDlWicI8PMFTpPNUS2ckc/hHp3yH/C/EfnAAoEAHihoDZOtMBEYgsBS6QgTFzYCuC AAA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/sp_jaxlymph.gif R0lGODlheAA8ANUAAGxgWoTJ0giUpTOOls3o7Rqaq49wZS+ks4OQjlKPkmC4xPr9/Uauux2IlLGU hW2VkRsXFp7T2zQqKCWTn8ikm6GEdgsJCTxiYdXZ4Up+gO32+snQ2yQWEUSWnrDa4hALCrvBy6qy vHTAzL7i57Cilg+Wp2NNQ0YzMBOOnF2ZnhgRD4uUnC4fG3Khqpehqt3h6nF6fAqUpCk0NZqajwyS ot7v9A6Tow4NDCEgIDVGR0dBPBIPDhWTohQTE6ejoU5SUSH5BAAAAAAALAAAAAB4ADwAAAb/QIbw QCweCkhkicZs0mLQqFRArVqv2Kx2y+16t8Ihw0hMFmgotFPKhn7f8LicqwiHyeVCCZVOM21PbAIx c4WGh1oKinZDZEh8fX82gFODCgGYYwEMcAEKXgwBB4hWngKXVKZbIoqtjI6QsTSTlFGWIwsRQgsB cAsjXgELnKRUvwK4xsCrIqyur2WxfGq0Nm3CnAy8vstc2MVXyQLHW5jNzs+NBygNDdKz1dZR39oB Ecsj+Vq/MQf5vQIY5BuFDZW/EZ+Q5es3MMCIGA79fRrRS9wxiAOtRMAU4FyrRY0muHMXK96kecNi aNOwYIEAYSLIXTlWgEGEYS9zuYRZI0LO/5g/fxW4WaMlsmHb+FkEpi0CAZdVIkjl6DEdkXZYIfHY Gg8KNpW5nubU1s0KOX84v+X0QCAVOWzHYIoVdpPTsaUBeYmj4kHqVHPNPg7BOpLPVq6TSlj7Wi+Z sJYHCM0EduBpWpw5F7Q1puETXGDYkpGFepc005YLRFjxwNrvRsDohAwg3O6wbcWTGOvdmWtQlmOa 6451WzRhzBpj4w7D1a9Gjc2lleVFHm4E675+qcaeTbvBBNuIbeh2yFtIwsnjKF5GJUwYUwVzkYJe 7hIi5ujp84oCSIUAgXzWtfZXVR0MkAFtKHwHHg/iDWNDYwuARUAN5w2C1icRaOBcWwos0P9TTu4F VIMGpz3lGX1uEaPcRBoQsaFPVTznH4ACvtYRKwwMoCN33k2gIHgHMFCADTURwQAUYWBREzFLBinA kgUIEOSUhAxBRZJSCulkllEGFFmRXGYppBXObfhfPjUCpkAHbBaoo49w/nhYNTHIU4kXkm2RJ556 yqFhmf6ded2ACiSQQJtu9vidnOGd1MaVoiBywCbBVHiIBpiWKaOg2G0kQgoJpCBqmzoq6iN4Xd2p liH1eCETIgtgmimgZwY4VQui5krqmxMg0attdNop2aqFtNrFq4e0JKustKLplwgt4JprCrv2WMCv c9IiiH2cYCSRAvpQBO4B4AKo3z2DODT/wigHoAYMRutiFIFEDlFhrlnKLvvnps5GEG200+46AJwL 0snGVzHgUk9lsTY8TLsExLSJw3k5Vd4xTYnVLksUBySxFRyzJDKzZjoL7QP/Sovomz0WrC1KRx71 MS4QC/dLPRm7BGFyp5EHhWYdWhzVNlVwHGvIJMvobAsPPDDtqIhOMLB3LmtLA8IxoGZvhL98czMv O2vTkmqf5TW2MjsfRTQVmCrr8NGzPodmCxfA0PTTiLIZJwpVM4G11kel5/UIOO82XRVla0Md2obj 8nHRqLmNNMkzwiBDDhfUjXfeE3TgI0mQOHF1SlDcBFUyXeP09cTk6Tcpz64DtHoyCq8t/wAGIbv9 NuUhWC7D5ZhnEOrwBRYfp4+GoTCJ35o9xO3WgquuAQHz7nzAi3k91eL1z8E4u0sdTljDKFS8sEFR DrcdObMgzGAAADn8/jvmF2Rg/wAJ7DiA5wOfuhXfkwiSEEqngW45aQxBipJmxlSkLQmwS3aI0gOv dAQEEkMMXRKABjCwgRcsK3Ig1MAGSOAABBjgBzrAXA5WuMLMZe5++jveYfzQhJ+Nzxa/KQs49nQF HmJqA+dTHwiVtQEKUMABDqgAAHSggx84sW4ZcOEFGnCgA2EFTtcC1vICQQgcFoMjRKBUKMh3BVVk AVMvAEEHR2Q01NQABEY8ogPcZwImNv8RAACQov32aKDZ9I9gwKrhoxDRj18Mo1XEqgKyyOScDYQA A2yM3BvjaEQkIvF9TERhDp64x07qjzsTSJAWAcHFO7GKaMYyxAtWuQEXIAAELxiR+XzgAEra8pJL zCQeYcBLGAjPUAnIQAwBma3ltYGHcjBWq8blkHkhBBm9EMi6rIABDm4ABAhwIgBQCIBaGhGOtjxi Bd5nAhPsspcZgEEwgdlHXiFvlEw45iGUuQ1srIQlveAHXaBCBSACEQQhAIAEBiqBExjAm+GsZBLJ CQAYzKCXEAWm8PR3RcOEp5SmjAM9e+G1iCVlPsSogj8BuoIcEFQCLDhBBUiQUDkicZz/ADCATHuJ AF42bZ0wdGeC+MYgWmDUixpFZT1VR7iPDscK/wSBC2BwUhagVAcVSKglX/q+hhqgAhWoKQIe0MsH 3E+Y+/sjT7P1hJ8WS6gcJWqrlBNSKoDgrSFYAURhoAMW2LWbt7SkOGVqgplmdQYrQIBgvfrLQ7HJ naEkqyDdgExQ8EIUiFSrUYWBiirANQQIWMEKXKBZy7GAAyw4aC1H601LytQA5rzqDFbLWbnazWmg EphIvsM3Gv7UDXFoVw1GUADuDWd1+enQhywbghC4UrPIlasEcMABlYZzqliVKR5VOwMfzMCVr71p bA/7uVDKwqdTaGwXrJSlMI0BTGOI/wGUrFBcV2Y2uZoFwGc5oAPRIlGhWB3naWW6Uh/4AAFZHezd trsjkYAOgIAgpSDAYQUeilcALuAsDOCbWc7+AAIcAO0JUpvf/F51v1clQQhm8FfBbvWmhnLTbAxs UYNti8Fz6CwA4JtcGJzArhywgAWaa86Ygni/UU3iHFc7AwE7jZ2lysooa4FbGMshsL/LrJSTu9Qf SIADH9CxBSCwYR//+LQVQOIMhmzkB6Q4yYpClTGB6uQ3rOAHPejBD0wsWBmbFAI7+ECeVZBlDeug x9Pl71SHvFojS7TAcRqlPNv8hRzsIM4QkIETc9BEHeCgBzq+wQ52oIIbfAACELiBjv8/8AEW9LXD YZ7qDEhA5BPfzbCIXlQxS1CCBTO6CzeI8w483QMIfCDOmX50lrX8ARXgwNcW+ECGTYDqVE+VBKxu ddNga9gCJfowtM52rR98ayvEuQebfvSmtZxrHFxay6MGNZ9VoOGDonrQDoC2D1wwgwecWFd685yP gsSDEhSJ1jEoARGsAKYnjcngGaTClqQUGYU33Eve7jUEvr1rdPe6B6ImN6mLzQEVqMDUV41uyJ0d b3nPu95Mw7e1JyDcCBRAAZhSAMBrEIA8+Wd7GiIAEjaUwfC1RQQxF0CGaC6ACbWoChDAgQzMjXFR 59rpFBf1DkCd5U9jmQPl/DJWn03/Av9etwUISDm1DjswD4hifARQBAFo3aGaQ+EAPvEUMDxQh7YQ IKR0F0ANBKIIYGxvAQfQQAFEACMBmJvpN8h44tN96cTfIOnHTjZzM5zS/cbUx2EOM7S7bl3AThtq /Eu7RBaAhAX4m0Rur1M/0o6Jl4iiM0dXeJTG55qASKmATOlGDnI98cVbIOM6BjWkJW5uCKiA6qBt LohJsAJBI3HznQf7qw0bpAjUICYdKn0J7IEJNmSoDp2heQH+lPCXECAGGdKAavoTgAKkRh9UAMAO ir8DcgPf8VUnvrGNX+z5ntYBanRNPhByzydvhTZth5ICduABI0AhpOd+43cPCNES/8QALvCCCXFH HsAAc6MAeO1CBU4RJeDCgFUAAzegdOemZfWngpsGbno2dSowbp9mVyDnANUERKsEAvllSdFmYk7T As9AdwzQImkHHwWACQOBJDUQAwpAd6pBOPYgdPyhDQdQAuNwBDtRAxLkE61HBRdwgkyHbmKYbJqG ZyoAbseGZ1ZHeSbgAxtwgxjASu6zdSRWZFvlAufgDKGgIfMCdJ2hBJhQa7XmHw8zPW0ReCNCRh5A IusSAJjSCxqyEDdHRjpgAT2AA8D3e4qXZ+CmYxI3db5Gar7GbiwAANUFRNUUhzmIagjgAiHwFx3h CopQBEKQBAJXhdumEuSzcDWRcP8CJCT9UIUqkSS9aAUyYIlOp4mJ9wGOZwFTV3+PB2q5hml6ZgEf JwHlNAMgkIrV9AI3GAL+FQJq1BogoCYggUB5oATatm1w4GDcZgU48HvKKHUY14JxpmkYp269Fo+c RmopNVA+wI3dyI2rtEojsAECYo53UAZHYIvZllG3BgHyqGlO94ycVnyQh2fGt2kSyWkcsAPNlVJu +IYDWZDduEoYcJAIGQHlGIvnaARmsI652G1I53i5Bo2PB2mHx3T11wN8howc2XE0aABqlIoFaZKq SAAvYCuvERgveQQNqY4Ax2aMholoGHmeiGcc6XEqQIZ5lmUeR2ogyQIY5lQjaZRHR4mScUgA1eQB G5AdTikGRWAGeqBtTdZtS7eTmKZjz5hxzJhlFrlu/HeNOHCNAICKJ1mQzoGSLzAjraEdTxmVdfmQ VOlkQQAAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/sp_ritafoundation.gif R0lGODlheAA8ANUAAIRKc8aylM66nM62lKqDhNa+nMaulM66lIpUdsaujNbEnL2rhKuWeaV8gsay jLile9bDpejTr862nMa2jL2qjJVketa+pc62jM6+lKF3fsauhLWTi7WkhNa+lN7Npd7Hpb2mhJpr fJtqgJ5xfN7MrdbDlK+LiN7HnL2mi7SchLucjZFeebudk5JieMCjjsGkk8uvk7KShLaYjN7Hrd7L nLqch76jkK6QhMepl8qxmZhnfM6+nMa2lNK3nsmzksGlmCH5BAAAAAAALAAAAAB4ADwAAAb/QAqH QzEMOAkDiDIQJAKBZgHymQUEWKikUMBiu16BZAANWARSSPcpHgympE+XS1ZMFhqMonM5XBwaGg59 DldTXUcGARQJWEZSFhZcURJebhAQFJoUURyKKEwSjRJjZGWVpgJqElBNaKYGmiggAbEGlayKblEF MzMWblisfg4OBx0deiV+fSUKA5UFkZOTRgGeUQJcdNpTkt6tlU6OBtoBEJJoAQlP0KYFcoucY2X1 UGi6rAniA4qqEgZmFYl1rMOBYheUMTvg7IMaMJMsQCAj4ForYW4gYUIXbMrGAZguTXSIiUsWaLUC 9CqgBIS1Rt0wffhAQo02NAkwAUvASdsA/01XBBwocMJDBw0PNBwgFmjQgQg1X1UC8aaJQ0pt1nFK g64AowUOPETA8OCBAwwYHCwA6yHtARptF0j5iaIcqbt3s/IEGkuTEQFrBSXsoODBAQ+FzXowqQ4K Aw5XziwqNmHphQkOJmjerPmxGYesdmUroACshgtwDzxYcKFEiT/GDq7tg1QbhIoBJEzMyDsMGZ42 CDTI0MCECgNLMXQgoCPGgQUHTnRYYFZBGVeTXGEhkxzDAcwaOHNuxdvUdW2rD+hRcLCyAgXe1QPS sLa+xzOqSODFa9tmgBsVbCDgcBUgAIAODbywgQwEsHaMbJmd1w1jWEj0ngIlYPDHAuJtVv/TT0Cx UosBuqi2ADILdbfUimgdFN4BO5gkDU3b1FhAExJJVoEM9bhxAAUVuKCDCyOUZZBml6nFmHkXeSTH hQZd1qFmNYnCyBW1sJNEADwk0JpBg3gnZR9+OMMeZgewZ0o0+IVxkiUBVHADeaQMkAEBKKwAglon HhSbkmCYV4Qqty0yQR+EvVfClBN4wR8UBmipCGnqLcQHQpYtM0FTEwxwwCJP0EPiqKOW5wYBBGSD EQIO3JCBipjF9oeEXDwxhRMpMABWQmbaMSUbOcI5KhQKnOCUdxOckJYxe0R3AXWnTZBAAfJEsY49 ZaixZgEs2JDbTQJsoMMFI9wAAgd6gJX/2aHH0OpVO/0IkUBm6sXH6GgP3cQkD8aAhcEyYSlwQWsn 7BGBag9MsExOooS6SCQQQxzVPR9E4M82AjTQgAMrZJABACi4kEELI/wxAQYnLFkGAykQcQUEHmRG ZqyMUviFTaa4kcIDoFwhgTGDFLzpwB0UTJhY1A6KjgBL3AIBCRFE4MQQdtWyRQGhIaBCDgC48AIC A8iAwAhv4FywhjTDp1ma7+0gIi8QJNCEPBJ80JNEN9Zy6xsSUFDsmhZ8kNYE7xWj3nsdoKnAjUl0 k5E43bACFKS3cMEKDhkEsEEGAoxggwEjSABDDjmYV0AyfmyGmB8rThDHjZGyo087WPR0/4g+U7jR BQWZqQEFBBEUYLifGbr2nTEdFJrNGBiJtrw8NVSgwwo6ILiBEw2wsAEACIgtwvcvJNGEp/WmHoFR ltGXhC6qyGEAEaoIEKkhlg/QyI0DSBIAHnS8sZhahwoPe+rlDLGsgjfr2FIw5AcPCAQABE27Wmic EBTdTaQeAgjcsVB3AQ8oK30L4EDT3lAFgDBiCxVRRDS2cz8oRIIH6rlHRaCzlswI0DIMKcpiEHEd EpEHJRaoyQMjaLls/OUVqiiCFMDArhUtJUoJ0VBOVrGIIfQkhW+4SBhUQi0u8uADHmCDACjAgDtw yGTv8VNl0KQNEb3BJCKKlEeS5hcJZv/DEOoYXwbRIYoTIauJxRhEBwDmqHWgYAjnSJoZeAM5VbAE JgEolqNiQR3oLEsPBwjEGhNQAQB48pOg9GQFRiCDX4SGDA0IZQWwI4JQuvKVyAPEIEzgSgSEQYlt MBV2ngaBWLhhWiUgwQwqIgEFgGA1yjFcWsCiAA8gppOvfGUDHjm+VIJylbZpZTS3CZ0OBPIAK3jl BqoFlJAwYRfYoUkvObGIApTgFFNIo8IQw6HAyOcB0NxmKDNgDO84wJqfrIAxnqZNfbqSF1EYQA2i mQHC0EA5sgHLAXjAiFsJYAYF4En83gAZHzZhBw4o1lJKkDhiyEwt+TSoJxEwswV8DJT/LSjLDiBQ UJV+8o7QGME2fUAYds0nTUP8BBPGiIKqYGkRP3xAM0sgSGQkY1McOoAOQkkAtJTATq50wVLU8tJP 6gADncpY9aQnAgOBEgE6GMH3qpcVLJj1lTdYimAwM4GifYAVY7CVBA6JJSPAzhVjWADKDvKggjxL sB6YKigJcCYNgMCVKljKpgDqyRAU7Atg0AYtr2mAu2riDcQMVyjD+ckQbHVm7iEBGrYjANV+Nm/6 6oZQKvOH6EzHKXcIaQQU+0kCkHRTjw0lB8h0AAKEsgULmGJmybDZgC7iXNOaCAWwUNMQGBeUyDnG Hkx2gJ/QohYDuMq05JBBn4XhGGlR/woNVCOIQF6gmbz1JAHShAEVtCCUrOqDcq4b0JN54Db6MgB/ PakDC7TiVkroJVUpEEoT9KFY7KEMqCwaBzJA4BdTmC6TPIUhNCXAMLI8FGZSqlIHD2wpAwaACAyI BgngbQCUPVCFtBWpzjbXkzA4wFsBsILMrMcgS9nBG6KmhqsYAB5diBsZNjEvB9BgLPVRaiaN8SwG 3NemAMhAhr6jmRjr4KoVkdvT5JDiFlAlC+c6xwd2XAEITECnoEwBa6BEGB7cggQk+Mm0NHqbqnR2 BuiQCFUcYr+6YQsKVzaoCF6gALXkgT1dFWUxzPKgzaS4AhsKD0QnkIJQNgAECdgeKP8zQISy2aQI WhkA1PbCCAFUbMwT2Uv+5CCEK7pJACRGAGk/iQACnI5PDLlApAFQgaXsKlZpSrEOvrMi2Ghg2BxY QC3wOxoe4hG8BRByGWzDBN9tYgofGCMSJmSj+AKAABLAwY4BYFqkOMgBw9bBIDMDCGZ6QNl8KBZT V7OAdQ8HVetmQTrIMD9CpdAAJdmOznKCn1vRQRHAuzUWzO1rAaQYACagzxnhHcplY0AQmhlEM5Wd lhLQczUxwLInG9Bne2hH4uqwleW2cNffDOoDuhwAxVO4bgRQAOSYibFAc6sHg+jh0hd4wAUKphYH wBnLCCgdGaARv2vh6ErWqkUQK0L/gSU0wn7nGgJkDk3iBozoxp4cwaEGdgGhF2POZ1uK25OiHsz4 QOWfNMECtREBnE9uiH5JKEgqcq5BxYsCh0xBzhO98nMOYN0AMEB8iqvKEyeKdRhQ9mGdcgC0ozUE Iqje9EIZgqshQoiUSOAmbAeTfqjkA9s2ycvDsGtPktokMnBlQ72T+Y4rhwY0iDCzlO0iTXeg9ueu THe18QNXwgATYU4gSOKBD6BksBxckIndQMsTlQhDCS5jPAA+bRMBmBsAMdBFilfQkyiE5AoxboHi 08C1UPYgAXVhRBPWbYLGsKOSRfMMZaEu9PEAJUEh5pER2RAvoBYnnkY/3OJKFVAG/162HZ8FIgNw aUHRBjE2AhbgS5AzbCuwF+dyPLLiAF6SKGDyBY1xDhMGAX2TUNWCCgmUDY0QEv6QDvTADp51Dh8y TFx0BRgVZn4FYKVQD0agBkmQWdFwgNtRBhcSUWBRGS2CgvBSBkfmejdhdf3gD6KSDxwQXg7EBB+g g1lCAR8iBRURPK4wZPjQOE/TJFQAhFVRBHGjC7yxEYwxFEUxHQPYXiFXH6gmeJGRN28gRhehCzhg AgRQARWwAhVAAD+wDq11aCpRElZzG0IAQfCDajkwTZEghzOBG2SwBAWwBG8UZkySJQPgDBhQSSej HPaiFqhGdQwkXnXjV3kTBaEWTv8I4IgV0ALSswIj8DLsoAiCRwG60UXA8xNEUGsDgIoNIAN95jyx Yz+3EAAokAAfWDYOsVphQAoHQSaUUSkmpQHsIHjQIA4UQi2EkgsBYAIhwCPkoSqRJwZ0YgniUAlU 0EWToBJFkAMIgDNIqCXX0gVGQF6l0D4b0ZAT8U2SJVl8sha+YQrh5n7xQEK3ETsisAEJAEE3qA4S AAAvwAoYEwYRcEHS8BPyUDvsFI+c4wUKpA04MIn7ABqtpYktMy159jhYIB94wBDP4UxxtxQHSIkf 0Gyx0nTHQFLeQQBRh0U8pAIAAAMBIQBRcwTT0gVaAUGaoHALpAYiYHZR0F2DAHz/F1ABNeAHCdAA P7cWzkQDBYMhGZIoF1IAn7IXlziIz8UBXaA/t5CUlrGU+oUif5AAKyACAJY7UGACK+AQ1IJn12AA EoFLYaaM+0EKatA9rWCWS3cCLsBSxQCVKBBIyNAiK7Iap7EeCrADjbEFd1gG+BeGAUBoUfAMzLCU ymGYKBgAX1Nx0uACMqAC1YMDtXN9tAAPSFAAeGZgtLBE6lAALxB5PyRACpABJbMWDRADnOdE9UIW q9FPyHCSXoCMkPJZtVko4zMw4oEW8ZEkT7A9LlAGKoAqADACeOIJjGgC22gCOMAJL4AD4TYCKYAC JtB/hbIBBBACCFAGMMCIBOAA/yWwAb9IADEAAg0whROAAqiCA+9hAjBwAgwieWLiADbSgvZwC2L4 CgOwLkjCdmyXHF0UjwTwG7fhAgCAA4twAyIgAzIAiRQgj5UgAqliAOM3AqlkAhCQA9YVACsQAlGw ASuwAThaAxiwUPiZABnAKg4AAsRRn12jADogHFD5VRJ5AIUUKQr4OLrTBSISSGsnWXSVEHepDT1Q KF3AHJjwNT0gBlRJASHggQKwAgRAAQs1gTAAACogAVO6CL02ACqAAIqAoxxwALkHAksxNsWQVhwy AYR6AQiAAD6wAB2jfN2lgBhUCktEO/jYZDLDIqlDhYeABZggCl2wAi+ACY2Ic/8BwAIiYAMAsAES gKMqoDkAQAoNEDosgACkcAMAYAMDUAEmAAUhgFzCFgLQwWAyUAwAsK0DswI1kAAY1yoj6J342CRg 2T612KpN1kRsY4IX4GdB8T4fwIi7sKUAAToSwAIA8AMmUCAqkKwNEAEssAIqYAINsAIGQKEGawJj agM6hSopQKgpEAMjgAAaEAMpN18K8AINZQIIcAA+sAIu4AIb0CyE0xj5gQgWZAUBcChMiRuu9iHl oImQsV0xsGsIEAIuABcFAwPaNAIGUAwhkGUGEKo1oAOxYCArYALT2Wu5p7SptAIxkEoEYAErFQIC iQANkIEGwrWEQQBxpVMIkAH/PKAZHeAB0hY4M0ETeBYV+TEDggmn6tA+wBAZ0ZgCTICXkRWXy6CC R2OC2lUCSdF0CkADXsFFFCEJElES+pAbJrEOM5FwQjEArFksahsel/FgpoZEriB9GYUcm6EWp0oo N+JiNssE9VFXzVIQ3/FeYpF0C9BMfigIzCQdC3gP6NCQ+JFQmCURbVsoCYAY3lECJwB8YpImc4mm b3gFaqi7mkAflaEWbrBCqyURMmtMgUFveeBP/gIXE7AatOsv6WVsrmke8eMml8BDrvAXdNB1SSkI x/AsiyJAiNGiWKgSeXYTY3AIBRCebMkD2pERunAREKBd8MFlKOJo9NV06wFW/8gACH4wu7ihKqbC giNiCC6zhXIDCHX1imUEi7JBdVP3NEtQC5twZAWwFspHBijkevKAAqDQDmwjMPSRB8lwAYHQGjJz GTl0RoJAGIN3ERQhDDMWKVeiCjOgfx6hBvTyHh/3AFHSlN5BBb7TDkckD31RKfrlABmUNA6zF+zA CA/CJ2fhDJdCXKmDKKyhww4wSAOgABXxRovgPLB5HuAWDhPCLGeiGZgbfA2xR3REAYEjTLuYBM4E VhfQATdIRwEAFWewg3HsTMtgvMoLHyfmAa+hfJuSJkx1Gl2KNU2ADg+kCRDUM+FFEmAQRzyxJf10 WITDIRpSSVo5NzUGm0kzBANyGwQAOw== ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: image/gif Content-Transfer-Encoding: base64 Content-Location: http://www.elymphnotes.org/images/lg_gatc_siteby_full.gif R0lGODlh6wANALMAALCwsDY2/HFx6Xx8fL6+yfLy8ubm5tnZ2Zubm2hoaM/Pz83NzTY2NszMzAAA AP///yH5BAAAAAAALAAAAADrAA0AAAT/UMlJq714Eua6908ojmRpnmiqrmzrvnDcKk09HRJO101O +wqdLngoHgybz0fGbDqf0KiUtKMJrtgroUfAErrZLICASJjNiEdS6UAZFgXYsVlYsOasun102PcX gHsjgHFTKHAtBgdMPwABj5CPAgQSApACDZGaAgydDAmdAyEKHEooAwwALQhpCWlMCwxqoiiuLAie DIshnYuguXy/uoYnDIInBgkPZYw0kAgUPAoEmls1lgGUAJ4ED3GFIQ2lICYFDLghin0idQYPyQPJ CAu774h1RXz3cAMJi+0kXC1wpygEngexVMELx2AArWXKSHwyUKBfCIAPjtBDuGvgQIBz/wpq7Fho YwhCy4wVtFfyjTt7L0cpQCDpAIAwPSxhkvQDGwGboVKs6XACgDJjKUEpO/Ap1bYERpumeaorVoKH uEAB0gUKAVNQqkQoTbXBXSoRDkWsdMi0EDM+w7zZ+Xp27C87nX6BKmCL2dg0xvh2QiAYVLJPzKgu ymvM6jkRQbAJUIANUgOaASZhA1DpESVcj1MAWGLCzIKrKdXIsojOFmpm504PiBXzgRmbWyE+6LcA nVhlsBFsAGfrwBlvsc/qHiSLBGtZqKMDBmCOurG+yl4fXbCtTgID87blDm5bVF1WDL6EfRDEUeYd mR7F15Q5p2egDl6dGNqmhIFcDBTATP8stqVBoGtpwHbGPM2JYFwnABDo1xkRhWCLhFc9tJso4KHy wDaeRPSWg3FVJA9C0LWi4gNItXhagtnByGJvFRbWmCyw2ZFjgRUNBlkNl3xBTWaSZcGTT9N4AoAB TDIpgjimlDBiKgOuBlyKBer2GAERNhgCKxUlgOFuS+lnG3DK/KdcCBtQBx50tPy3yIgiTNRjmKkh mKWLM9piEXYzdidegEyNF2N5MxYIgCi+scdFZfS9Z8R8XXgmQVQARkQKG6Vh5YoyBNKlCipGybgB KAQQOMKpqRC4jVdSjTBWWHuRANpg/3VjIaMVOihMN6JmqSefxmT1SZY58gWWOb/8hJiaMool6sp/ oDxURQNd3KStADdRIg2Xk3QhnA0NAMDKuarwRw4JiFw00D97YNROSLu4JJd/A93LkVz1GGRvCGmV oIe7IxS0UgkoufvSHAy7g8jDcfQhEkGLtGtSHQUw/G46FkfsDj4jwNdDEUQMIbINB6DMgw0SLCAB EuNESczMK+ByDM0454xCBjz3nAGIbBCl89AO1kb00TlHAAA7 ------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: application/octet-stream Content-Transfer-Encoding: quoted-printable Content-Location: http://www.elymphnotes.org/ Lymphedema Awareness Foundation (LAF): eLymphNotes, an Online = Lymphedema Magazine=96Lymphedema Treatment & Care Information, = Resources, Support Groups & News
3D'eLymphNotes
3D""
3D""3D'UltimateHealth'3D""3D""
3D""3D'Home'3D'Current3D'Past3D'Resources'3D'Forums'3D'About3D'Contact3D'Site
3D""
3D""3D""
3D'Subscribe
3D""
3D'Make
3D""
3D'Coming
3D""Link to Us
3D""
Log = In
3D""
Subscribe
3D""
Contributors
3D""
Advertising Info
3D""
Product = Showcase
3D""
Classifieds
3D""
Press Room
3D""
Editor's = Desk
3D""
Features
3D""
On = Bandages
3D""
On Legislation
3D""
On = Marketing
3D""
On Research
3D""
Patient = Corner
3D""
Therapist Corner
3D""

Welcome Tina Budde to the eLymphNotes Editorial = Team
As Forum Coordinator, she will be = generating hot discussions like the...Read On
3D""
What is Lymphedema?
an = abnormal swelling
of the body...Read On


See All Core = Content

3D""
3D""
3D""
3D""
3D'Featured
3D""
Maximize All = Detoxification Options
by Kathy = "Z" Zanardelli

3D""
From the time of my breast cancer surgery and treatments, I = knew that something was not right with my right arm. I followed all of = the post surgical care guidelines, but it still felt heavy and hot on = the inside, with a frozen shoulder. Within six months, that arm blew = up, thus beginning my experiences with the traditional lymphedema (LE) = treatment protocol of Manual Lymphatic Drainage (MLD) therapy and = wearing a customized compression garment. Although the swelling was = mildly reduced with MLD therapy, I still experienced heaviness, hotness, = fatigue, and continued pain in my arm that the compression garment did = not relieve. In time, the lymphedema symptoms were progressing to my = entire affected breast, torso and middle back. These lymphedema = symptoms caught my doctor's attention and sympathy, but he knew of no = remaining treatment options for me. =20

Now what? With pain as a great motivator for effective results, I = continued to study. What is lymphedema? How does it...Read On

3D""
See the Current = Issue
3D""
See Past Issues
3D""
3D""3D'Recent
The LAF mourns the loss of Preston Parkerson, LAF Patient = Fund Manager
Preston S. Parkerson, 48, = passed away Saturday, January 7, 2006, he was one of the first Lymphatic = Therapists in Florida and...Read On
3D""
4 Keys Points to Preserve = Patient Access to Physical & Rehab Med
CMS has overstepped it authority in making a rule that is = unauthorized by congress...rewrite legislation so that it reflects...Read = On
3D""
CMS CHALLENGED AT CAPITOL HILL PRESS = BRIEFING
The policy in dispute was = revised without Congressional approval and began enforcing in June...Read = On
3D""
See = all News
3D''
3D'Care
Tips for Healthy Nails
Here are five steps to follow for strong, healthy, = beautiful...Read = On
3D""
See = all Tips
Send in Your = Tip
3D""3D'Forum
Q&A by Brandy McKneown
Support Group Ideas, Facial Swelling, LE Pain, Why Am = I...Read = On
3D""
See = all Q & A
Send in Your = Question
3D""3D'Resources'
The Dorton Directory
3D""
The Fran Glossary
3D""
Community Networks
3D""
Events
3D""3D""
3D'Sponsors'
3D""
3D""3D'GAT
3D""
3D'The
3D""
3D'The
3D""

3D""
Advertising = Opportunities

3D""
  

Home  |  Current Issue  |  Events  |  Terms & Conditions  |  Privacy = Policies  |  Donate  |  Link = to Us

© = 2008 eLymphNotes, The First Online Magazine on Lymphedema
Published = by The Lymphedema Awareness Foundation (LAF), The Community = Network
172 Lakeside Circle, Sanford, FL 32773
laf@elymphnotes.org

3D""
3D'Designed,
  
------=_NextPart_000_0000_01C8EDC3.EAE486B0 Content-Type: text/css; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable Content-Location: http://www.elymphnotes.org/include/style.css BODY { FONT-SIZE: medium; BACKGROUND: url(../images/bg_elymphnotes.gif) fixed = no-repeat 50% top; COLOR: #000000; FONT-FAMILY: Arial, Helvetica, = sans-serif } .Note { FONT-WEIGHT: bold; FONT-SIZE: 10px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif } .Small { FONT-SIZE: 11px; BACKGROUND: none transparent scroll repeat 0% 0%; = COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif } .SmallBold { FONT-WEIGHT: bold; FONT-SIZE: 11px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif } .Text { FONT-SIZE: 12px; BACKGROUND: none transparent scroll repeat 0% 0%; = COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif } A.SmallBoldLink { FONT-WEIGHT: bold; FONT-SIZE: 11px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #666699; FONT-FAMILY: Arial, Helvetica, sans-serif; = TEXT-DECORATION: none } A.SmallBoldLink:hover { FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: #666699; FONT-FAMILY: Arial, = Helvetica, sans-serif; TEXT-DECORATION: underline } .TextBold { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif; = TEXT-DECORATION: none } A.TextBold { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #666699; FONT-FAMILY: Arial, Helvetica, sans-serif; = TEXT-DECORATION: none } A.TextBold:hover { FONT-WEIGHT: bold; FONT-SIZE: 12px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #666699; FONT-FAMILY: Arial, Helvetica, sans-serif; = TEXT-DECORATION: underline } .Large { FONT-SIZE: 14px; BACKGROUND: none transparent scroll repeat 0% 0%; = COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif } .Title { FONT-WEIGHT: bold; FONT-SIZE: 16px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #000000; FONT-FAMILY: Arial, Helvetica, sans-serif } .spacer { FONT-WEIGHT: bold; FONT-SIZE: 16px; BACKGROUND: none transparent scroll = repeat 0% 0%; COLOR: #ffffff; FONT-FAMILY: Arial, Helvetica, sans-serif } .ErrorMessage { FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: red; FONT-FAMILY: Arial, = Helvetica, sans-serif; BACKGROUND-COLOR: yellow } .EditLink { FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: red; FONT-FAMILY: Arial, = Helvetica, sans-serif; BACKGROUND-COLOR: transparent } .EditLinkLight { FONT-WEIGHT: bold; FONT-SIZE: 11px; COLOR: yellow; FONT-FAMILY: Arial, = Helvetica, sans-serif; BACKGROUND-COLOR: transparent } ------=_NextPart_000_0000_01C8EDC3.EAE486B0--